<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://ajpcell.physiology.org">
<title>AJP: Cell Physiology recent issues</title>
<link>http://ajpcell.physiology.org</link>
<description>AJP: Cell Physiology RSS feed -- recent issues</description>
<prism:eIssn>1522-1563</prism:eIssn>
<prism:publicationName>AJP: Cell Physiology</prism:publicationName>
<prism:issn>0363-6143</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/full/297/5/C1059?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1062?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1071?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1082?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/1091?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1103?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1113?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/1124?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1133?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1146?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1157?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1168?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1178?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1188?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1200?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1211?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1220?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1228?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1236?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1249?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1263?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1275?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1284?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1294?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1307?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1318?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/full/297/4/C797?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/full/297/4/C800?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C802?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C814?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C823?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C835?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C845?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C855?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C865?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C876?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C886?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C898?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C907?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C916?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C928?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C935?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C945?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C955?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C971?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C979?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C990?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C1001?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C1012?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C1019?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C1028?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C1041?rss=1" />
  <rdf:li rdf:resource="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C1053?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://ajpcell.physiology.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://ajpcell.physiology.org/icons/banner/title.gif">
<title>AJP: Cell Physiology</title>
<url>http://ajpcell.physiology.org/icons/banner/title.gif</url>
<link>http://ajpcell.physiology.org</link>
</image>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/full/297/5/C1059?rss=1">
<title><![CDATA[Angiotensin II type-1 receptor regulates RhoA and Rho-kinase/ROCK activation via multiple mechanisms. Focus on "Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells"]]></title>
<link>http://ajpcell.physiology.org/cgi/content/full/297/5/C1059?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Kimura, K., Eguchi, S.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:44 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00399.2009</dc:identifier>
<dc:title><![CDATA[Angiotensin II type-1 receptor regulates RhoA and Rho-kinase/ROCK activation via multiple mechanisms. Focus on "Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells"]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1061</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1059</prism:startingPage>
<prism:section>EDITORIAL FOCUS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1062?rss=1">
<title><![CDATA[Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1062?rss=1</link>
<description><![CDATA[
<p>Angiotensin II (ANG II) is a major regulator of blood pressure that essentially acts through activation of ANG II type 1 receptor (AT1R) of vascular smooth muscle cells (VSMC). AT1R activates numerous intracellular signaling pathways, including the small G protein RhoA known to control several VSMC functions. Nevertheless, the mechanisms leading to RhoA activation by AT1R are unknown. RhoA activation can result from activation of RhoA exchange factor and/or inhibition of Rho GTPase-activating protein (GAP). Here we hypothesize that a RhoGAP could participate to RhoA activation induced by ANG II in rat aortic VSMC. The knockdown of the RhoGAP p190A by small interfering RNA (siRNA) abolishes the activation of RhoA-Rho kinase pathway induced after 5 min of ANG II (0.1 &micro;M) stimulation in rat aortic VSMC. We then show that AT1R activation induces p190A dephosphorylation and inactivation. In addition, expression of catalytically inactive or phosphoresistant p190A mutants increases the basal activity of RhoA-Rho kinase pathway, whereas phosphomimetic mutant inhibits early RhoA activation by ANG II. Using siRNA and mutant overexpression, we then demonstrate that the tyrosine phosphatase SHP2 is necessary for <I>1</I>) maintaining p190A basally phosphorylated and activated by the tyrosine kinase c-Abl, and <I>2</I>) inducing p190A dephosphorylation and RhoA activation in response to AT1R activation. Our work then defines p190A as a new mediator of RhoA activation by ANG II in VSMC.</p>
]]></description>
<dc:creator><![CDATA[Bregeon, J., Loirand, G., Pacaud, P., Rolli-Derkinderen, M.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:44 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00174.2009</dc:identifier>
<dc:title><![CDATA[Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1070</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1062</prism:startingPage>
<prism:section>RECEPTORS AND SIGNAL TRANSDUCTION</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1071?rss=1">
<title><![CDATA[Loss of the apical V-ATPase a-subunit VHA-6 prevents acidification of the intestinal lumen during a rhythmic behavior in C. elegans]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1071?rss=1</link>
<description><![CDATA[
<p>In <I>Caenorhabditis elegans</I>, oscillations of intestinal pH contribute to the rhythmic defecation behavior, but the acid-base transport mechanisms that facilitate proton movement are not well understood. Here, we demonstrate that VHA-6, an intestine-specific a-subunit of the H<sup>+</sup>-K<sup>+</sup>-ATPase complex (V-ATPase), resides in the apical membrane of the intestinal epithelial cells and is required for luminal acidification. Disruption of the <I>vha-6</I> gene led to early developmental arrest; the arrest phenotype could be complemented by expression of a fluorescently labeled <I>vha-6</I> transgene. To study the contribution of <I>vha-6</I> to pH homeostasis in larval worms, we used a partial reduction of function through postembryonic single-generation RNA interference. We demonstrate that the inability to fully acidify the intestinal lumen coincides with a defect in pH recovery of the intestinal epithelial cells, suggesting that VHA-6 is essential for proton pumping following defecation. Moreover, intestinal dipeptide accumulation and fat storage are compromised by the loss of VHA-6, suggesting that luminal acidification promotes nutrient uptake in worms, as well as in mammals. Since acidified intracellular vesicles and autofluorescent storage granules are indistinguishable between the <I>vha-6</I> mutant and controls, it is likely that the nutrient-restricted phenotype is due to a loss of plasma membrane V-ATPase activity specifically. These data establish a simple genetic model for proton pump-driven acidification. Since defecation occurs at 45-s intervals in worms, this model represents an opportunity to study acute regulation of V-ATPase activity on a short time scale and may be useful in the study of alternative treatments for acid-peptic disorders.</p>
]]></description>
<dc:creator><![CDATA[Allman, E., Johnson, D., Nehrke, K.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:44 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00284.2009</dc:identifier>
<dc:title><![CDATA[Loss of the apical V-ATPase a-subunit VHA-6 prevents acidification of the intestinal lumen during a rhythmic behavior in C. elegans]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1081</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1071</prism:startingPage>
<prism:section>MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1082?rss=1">
<title><![CDATA[An environmental sensor, TRPV4 is a novel regulator of intracellular Ca2+ in human synoviocytes]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1082?rss=1</link>
<description><![CDATA[
<p>The activation of a vanilloid type 4 transient receptor potential channel (TRPV4) has an obligatory role in regulation of intracellular Ca<sup>2+</sup> (Ca<sup>2+</sup><SUB>i</SUB>) in several types of cells including vascular and sensory organs. In this study, we provide evidence that TRPV4 is a functional regulator of Ca<sup>2+</sup><SUB>i</SUB> in human synoviocytes. Although significant expression of TRPV4 in synoviocytes from patients with (RA) and without (CTR) rheumatoid arthritis was detected at mRNA and protein level, those in the human fibroblast-like synoviocyte line MH7A were rather lower. Consistently, the selective TRPV4 agonist 4-phorbol 12,13-didecanoate (4PDD) effectively elevated Ca<sup>2+</sup><SUB>i</SUB> in the RA and CTR cells, which was abolished by the removal of external Ca<sup>2+</sup>. Moreover, the elevation was inhibited by ruthenium red, a blocker of TRPVs. In MH7A cells transfected with human TRPV4 (MH7A-V4), 4PDD elevated the Ca<sup>2+</sup><SUB>i</SUB> in a similar manner to those in the RA and CTR cells. Electrophysiological analysis also revealed that 4PDD activated nonselective cationic currents in RA cells. Application of 227 mosM solution to the RA and MH7A-V4 cells elevated their Ca<sup>2+</sup><SUB>i</SUB>, but this does not occur when it was applied to MH7A cells. Treatment of RA but not MH7A cells with 4PDD for 24 h reduced their production of IL-8. These results suggest that an environmental sensor, TRPV4, is a novel regulator of intracellular Ca<sup>2+</sup> in human synoviocytes.</p>
]]></description>
<dc:creator><![CDATA[Itoh, Y., Hatano, N., Hayashi, H., Onozaki, K., Miyazawa, K., Muraki, K.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:44 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00204.2009</dc:identifier>
<dc:title><![CDATA[An environmental sensor, TRPV4 is a novel regulator of intracellular Ca2+ in human synoviocytes]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1090</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1082</prism:startingPage>
<prism:section>MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/1091?rss=1">
<title><![CDATA[Bicarbonate homeostasis in excitable tissues: role of AE3 Cl-/HCOFormula exchanger and carbonic anhydrase XIV interaction]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/1091?rss=1</link>
<description><![CDATA[
<p>Bicarbonate transport and metabolism are key elements of normal cellular function. Two alternate transcripts of anion exchanger 3 (AE3), full-length (AE3fl) and cardiac (AE3c), are expressed in central nervous system (CNS), where AE3 catalyzes electroneutral Cl<sup>&ndash;</sup>/HCO<f><SUB>3</SUB><sup>&ndash;</sup></f> exchange across the plasma membrane of neuronal and glial cells of CNS. Anion exchanger isoforms, AE3fl and AE3c, associate with the carbonic anhydrases (CA) CAII and CAIV, forming a HCO<f><SUB>3</SUB><sup>&ndash;</sup></f> transport metabolon, to maximize HCO<f><SUB>3</SUB><sup>&ndash;</sup></f> flux across the plasma membrane. CAXIV, with catalytic domain anchored to the extracellular surface, is also expressed in CNS. Here physical association of AE3 and CAXIV was examined by coimmunoprecipitation experiments, using mouse brain and retinal lysates. CAXIV immunoprecipitated with anti-AE3 antibody, and both AE3 isoforms were immunoprecipitated using anti-CAXIV antibody, indicating CAXIV and AE3 interaction in the CNS. Confocal images revealed colocalization of CAXIV and AE3 in M&uuml;ller and horizontal cells, in the mouse retina. Cl<sup>&ndash;</sup>/HCO<f><SUB>3</SUB><sup>&ndash;</sup></f> exchange activity of AE3fl was investigated in transiently transfected human embryonic kidney 293 cells, using intracellular fluorescence measurements of BCECF, to monitor intracellular pH. CAXIV increased the rate of AE3fl-mediated HCO<f><SUB>3</SUB><sup>&ndash;</sup></f> transport by up to 120%, which was suppressed by the CA inhibitor acetazolamide. Association of AE3 and CAXIV may represent a mechanism to enhance disposal of waste CO<SUB>2</SUB> and to balance pH in excitable tissues.</p>
]]></description>
<dc:creator><![CDATA[Casey, J. R., Sly, W. S., Shah, G. N., Alvarez, B. V.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:44 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00177.2009</dc:identifier>
<dc:title><![CDATA[Bicarbonate homeostasis in excitable tissues: role of AE3 Cl-/HCOFormula exchanger and carbonic anhydrase XIV interaction]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>1102</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1091</prism:startingPage>
<prism:section>MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1103?rss=1">
<title><![CDATA[Orai1, a critical component of store-operated Ca2+ entry, is functionally associated with Na+/Ca2+ exchanger and plasma membrane Ca2+ pump in proliferating human arterial myocytes]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1103?rss=1</link>
<description><![CDATA[
<p>Ca<sup>2+</sup> entry through store-operated channels (SOCs) in the plasma membrane plays an important role in regulation of vascular smooth muscle contraction, tone, and cell proliferation. The C-type transient receptor potential (TRPC) channels have been proposed as major candidates for SOCs in vascular smooth muscle. Recently, two families of transmembrane proteins, Orai [also known as Ca<sup>2+</sup> release-activated Ca<sup>2+</sup> channel modulator (CRACM)] and stromal interacting molecule 1 (STIM1), were shown to be essential for the activation of SOCs mainly in nonexcitable cells. Here, using small interfering RNA, we show that Orai1 plays an essential role in activating store-operated Ca<sup>2+</sup> entry (SOCE) in primary cultured proliferating human aortic smooth muscle cells (hASMCs), whereas Orai2 and Orai3 do not contribute to SOCE. Knockdown of Orai1 protein expression significantly attenuated SOCE. Moreover, inhibition of Orai1 downregulated expression of Na<sup>+</sup>/Ca<sup>2+</sup> exchanger type 1 (NCX1) and plasma membrane Ca<sup>2+</sup> pump isoform 1 (PMCA1). The rate of cytosolic free Ca<sup>2+</sup> concentration decay after Ca<sup>2+</sup> transients in Ca<sup>2+</sup>-free medium was also greatly decreased under these conditions. This reduction of Ca<sup>2+</sup> extrusion, presumably via NCX1 and PMCA1, may be a compensation for the reduced SOCE. Immunocytochemical observations indicate that Orai1 and NCX1 are clustered in plasma membrane microdomains. Cell proliferation was attenuated in hASMCs with disrupted Orai1 expression and reduced SOCE. Thus Orai1 appears to be a critical component of SOCE in proliferating vascular smooth muscle cells, and may therefore be a key player during vascular growth and remodeling.</p>
]]></description>
<dc:creator><![CDATA[Baryshnikov, S. G., Pulina, M. V., Zulian, A., Linde, C. I., Golovina, V. A.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:44 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00283.2009</dc:identifier>
<dc:title><![CDATA[Orai1, a critical component of store-operated Ca2+ entry, is functionally associated with Na+/Ca2+ exchanger and plasma membrane Ca2+ pump in proliferating human arterial myocytes]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1112</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1103</prism:startingPage>
<prism:section>MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1113?rss=1">
<title><![CDATA[Identification of Sp1 and GC-boxes as transcriptional regulators of mouse Dag1 gene promoter]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1113?rss=1</link>
<description><![CDATA[
<p>Dystroglycan is a widely expressed adhesion complex that anchors cells to the basement membrane and is involved in embryonic development and differentiation. Dystroglycan expression is frequently reduced in human dystrophies and malignancies, and its molecular functions are not completely understood. Several posttranslational mechanisms have been identified that regulate dystroglycan expression and/or function, while little is known about how expression of the corresponding <I>Dag1</I> gene is regulated. This study aimed to clone the <I>Dag1</I> gene promoter and to characterize its regulatory elements. Analysis of the mouse <I>Dag1</I> gene 5'-flanking region revealed a TATA and CAAT box-lacking promoter including a GC-rich region. Transfection studies with serially deleted promoter constructs allowed us to identify a minimal promoter region containing three Specificity protein 1 (Sp1) sites and an E-box. Sp1 binding was confirmed by chromatin immunoprecipitation assay, and Sp1 downregulation reduced dystroglycan expression in muscle cells. Treatment with 5-aza-2'-deoxycytidine and/or the histone deacetylase inhibitor trichostatin A increased <I>Dag1</I> mRNA expression levels in myoblasts, and methylation decreased promoter activity in vitro. Furthermore, <I>Dag1</I> gene promoter methylation was reduced while its expression increased during differentiation of C<SUB>2</SUB>C<SUB>12</SUB> myoblast cells in myotubes. In conclusion, for the first time we have characterized the activity of the mouse <I>Dag1</I> gene promoter, confirming a complex regulation by Sp1 transcription factor, DNA methylation, and histone acetylation, which might be relevant for a better understanding of the physiopathology of the dystroglycan complex.</p>
]]></description>
<dc:creator><![CDATA[Rettino, A., Rafanelli, F., Genovese, G., Goracci, M., Cifarelli, R. A., Cittadini, A., Sgambato, A.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:44 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00189.2009</dc:identifier>
<dc:title><![CDATA[Identification of Sp1 and GC-boxes as transcriptional regulators of mouse Dag1 gene promoter]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1123</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1113</prism:startingPage>
<prism:section>MUSCLE CELL BIOLOGY AND CELL MOTILITY</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/1124?rss=1">
<title><![CDATA[Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/1124?rss=1</link>
<description><![CDATA[
<p>Myostatin is a highly conserved negative regulator of skeletal muscle growth. Loss of functional myostatin in cattle, mice, sheep, dogs, and humans results in increased muscle mass. The molecular mechanisms responsible for this increase in muscle growth are not fully understood. Previously, we have reported that phenylephrine-induced cardiac muscle growth and Akt activation are enhanced in myostatin knockout mice compared with controls. Here we report that skeletal muscle from myostatin knockout mice show increased Akt protein expression and overall activity at baseline secondary to an increase in Akt mRNA. We examined the functional role of myostatin modulation of Akt in C2C12 myotubes, a well-established in vitro model of skeletal muscle hypertrophy. Adenoviral overexpression of myostatin attenuated the insulin-like growth factor-I (IGF-I)-mediated increase in myotube diameter, as well as IGF-I-stimulated Akt phosphorylation. Inhibition of myostatin by overexpression of the NH<SUB>2</SUB>-terminal portion of myostatin was sufficient to increase myotube diameter and Akt phosphorylation. Coexpression of myostatin and constitutively active Akt (myr-Akt) restored the increase in myotube diameter. Conversely, expression of dominant negative Akt (dn-Akt) with the inhibitory myostatin propeptide blocked the increase in myotube diameter. Of note, ribosomal protein S6 phosphorylation and atrogin-1/muscle atrophy F box mRNA were increased in skeletal muscle from myostain knockout mice. Together, these data suggest myostatin regulates muscle growth at least in part through regulation of Akt.</p>
]]></description>
<dc:creator><![CDATA[Morissette, M. R., Cook, S. A., Buranasombati, C., Rosenberg, M. A., Rosenzweig, A.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:44 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00043.2009</dc:identifier>
<dc:title><![CDATA[Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>1132</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>1124</prism:startingPage>
<prism:section>MUSCLE CELL BIOLOGY AND CELL MOTILITY</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1133?rss=1">
<title><![CDATA[Negative modulation of inositol 1,4,5-trisphosphate type 1 receptor expression prevents dystrophin-deficient muscle cells death]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1133?rss=1</link>
<description><![CDATA[
<p>Evidence for a modulatory effect of cyclosporin A (CsA) on calcium signaling and cell survival in dystrophin-deficient cells is presented. Our previous works strongly supported the hypothesis of an overactivation of Ca<sup>2+</sup> release via inositol 1,4,5-trisphosphate (IP3) receptors (IP3R) in dystrophin-deficient cells, both during membrane depolarization and at rest, through spontaneous Ca<sup>2+</sup> release events. Forced expression of mini-dystrophin in these cells contributed, during stimulation and in resting condition, to the recovery of a controlled calcium homeostasis. In the present work, we demonstrate that CsA exposure displayed a dual-modulator effect on calcium signaling in dystrophin-deficient cells. Short-time incubation induced a decrease of IP3-dependent calcium release, leading to patterns of release similar to those observed in myotubes expressing mini-dystrophin, whereas long-time incubation reduced the expression of the type I of IP3 receptors (IP3R-1) RNA levels. Moreover, both IP3R-1 knockdown and blockade through 2-aminoethoxydiphenyle borate or CsA induced improved survival of dystrophin-deficient myotubes, demonstrating the cell death dependence on the IP3-dependent calcium signaling as well as the protective effect of CsA. Inhibition of the IP3 pathway could be a very interesting approach for reducing the natural cell death of dystrophin-deficient cells in development.</p>
]]></description>
<dc:creator><![CDATA[Mondin, L., Balghi, H., Constantin, B., Cognard, C., Sebille, S.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:44 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00048.2009</dc:identifier>
<dc:title><![CDATA[Negative modulation of inositol 1,4,5-trisphosphate type 1 receptor expression prevents dystrophin-deficient muscle cells death]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1145</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1133</prism:startingPage>
<prism:section>MUSCLE CELL BIOLOGY AND CELL MOTILITY</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1146?rss=1">
<title><![CDATA[Retinoic acid-induced nNOS expression depends on a novel PI3K/Akt/DAX1 pathway in human TGW-nu-I neuroblastoma cells]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1146?rss=1</link>
<description><![CDATA[
<p>Neuronal nitric oxide synthase (nNOS)-derived nitric oxide (NO) acts as a neurotransmitter and intracellular signaling molecule in the central and peripheral nervous system. NO regulates multiple processes like neuronal development, plasticity, and differentiation and is a mediator of neurotoxicity. The <I>nNOS</I> gene is highly complex with 12 alternative first exons, exon 1a&ndash;1l, transcribed from distinct promoters, leading to nNOS variants with different 5'-untranslated regions. Transcriptional control of the <I>nNOS</I> gene is not understood in detail. To investigate regulation of <I>nNOS</I> gene expression by retinoic acid (RA), we used the human neuroblastoma cell line TGW-nu-I as a model system. We show that RA induces <I>nNOS</I> transcription in a protein synthesis-dependent fashion. We identify the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway and the atypical orphan nuclear receptor DAX1 (NR0B1) as critical mediators involved in RA-induced <I>nNOS</I> gene transcription. RA treatment increases DAX1 expression via PI3K/Akt signaling. Upregulation of DAX1 expression in turn induces nNOS transcription in response to RA. These results identify nNOS as a target gene of a novel RA/PI3K/Akt/DAX1-dependent pathway in human neuroblastoma cells and stress the functional importance of the transcriptional regulator DAX1 for nNOS gene expression in response to RA treatment.</p>
]]></description>
<dc:creator><![CDATA[Nagl, F., Schonhofer, K., Seidler, B., Mages, J., Allescher, H.-D., Schmid, R. M., Schneider, G., Saur, D.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:44 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00034.2009</dc:identifier>
<dc:title><![CDATA[Retinoic acid-induced nNOS expression depends on a novel PI3K/Akt/DAX1 pathway in human TGW-nu-I neuroblastoma cells]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1156</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1146</prism:startingPage>
<prism:section>RECEPTORS AND SIGNAL TRANSDUCTION</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1157?rss=1">
<title><![CDATA[The C type natriuretic peptide receptor tethers AHNAK1 at the plasma membrane to potentiate arachidonic acid-induced calcium mobilization]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1157?rss=1</link>
<description><![CDATA[
<p>Arachidonic acid (AA) liberated from membrane phospholipids is known to activate phospholipase C 1 (PLC1) concurrently with AHNAK in nonneuronal cells. The recruitment of AHNAK from the nucleus is required for it to activate PLC1 at the plasma membrane. Here, we identify the C-type natriuretic peptide receptor (NPR-C), an atypical G protein-coupled receptor, as a protein binding partner for AHNAK1 in various cell types. Mass spectrometry and MASCOT analysis of excised bands from NPR-C immunoprecipitation studies revealed multiple signature peptides corresponding to AHNAK1. Glutathione <I>S</I>-transferase (GST) pulldown assays using GST- AHNAK1 fusion proteins corresponding to each of the distinct domains of AHNAK1 showed the C1 domain of AHNAK1 associates with NPR-C. The role of NPR-C in mediating AA-dependent AHNAK1 calcium signaling was explored in various cell types, including 3T3-L1 preadipocytes during the early stages of differentiation. Sucrose density gradient centrifugation studies showed AHNAK1 resides in the nucleus, cytoplasm, and at the plasma membrane, but small interfering RNA (siRNA)-mediated knockdown of NPR-C resulted in AHNAK1 accumulation in the nucleus. Overexpression of a portion of AHNAK1 resulted in augmentation of intracellular calcium mobilization, whereas siRNA-mediated knockdown of NPR-C or AHNAK1 protein resulted in attenuation of intracellular calcium mobilization in response to phorbol 12-myristate 13-acetate. We characterize the novel association between AHNAK1 and NPR-C and provide evidence that this association potentiates the AA-induced mobilization of intracellular calcium. We address the role of intracellular calcium in the various cell types that AHNAK1 and NPR-C were found to associate.</p>
]]></description>
<dc:creator><![CDATA[Alli, A. A., Gower, W. R.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:45 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00219.2009</dc:identifier>
<dc:title><![CDATA[The C type natriuretic peptide receptor tethers AHNAK1 at the plasma membrane to potentiate arachidonic acid-induced calcium mobilization]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1167</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1157</prism:startingPage>
<prism:section>RECEPTORS AND SIGNAL TRANSDUCTION</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1168?rss=1">
<title><![CDATA[T-cadherin is located in the nucleus and centrosomes in endothelial cells]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1168?rss=1</link>
<description><![CDATA[
<p>T-cadherin (H-cadherin, cadherin 13) is upregulated in vascular proliferative disorders and in tumor-associated neovascularization and is deregulated in many cancers. Unlike canonical cadherins, it lacks transmembrane and intracellular domains and is attached to the plasma membrane via a glycosylphosphatidylinositol anchor. T-cadherin is thought to function in signaling rather than as an adhesion molecule. Some interactive partners of T-cadherin at the plasma membrane have recently been identified. We examined T-cadherin location in human endothelial cells using confocal microscopy and subcellular fractionation. We found that a considerable proportion of T-cadherin is located in the nucleus and in the centrosomes. T-cadherin colocalized with a centrosomal marker -tubulin uniformly throughout the cell cycle at least in human umbilical vein endothelial cells. In the telophase, T-cadherin transiently concentrated in the midbody and was apparently degraded. Its overexpression resulted in an increase in the number of multinuclear cells, whereas its downregulation by small interfering RNA led to an increase in the number of cells with multiple centrosomes. These findings indicate that deregulation of T-cadherin in endothelial cells may lead to disturbances in cytokinesis or centrosomal replication.</p>
]]></description>
<dc:creator><![CDATA[Andreeva, A. V., Kutuzov, M. A., Tkachuk, V. A., Voyno-Yasenetskaya, T. A.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:45 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00237.2009</dc:identifier>
<dc:title><![CDATA[T-cadherin is located in the nucleus and centrosomes in endothelial cells]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1177</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1168</prism:startingPage>
<prism:section>VASCULAR BIOLOGY</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1178?rss=1">
<title><![CDATA[Estradiol-mediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR 30]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1178?rss=1</link>
<description><![CDATA[
<p>Recent studies suggest that the rapid and nongenomic effects of estradiol may be mediated through the G protein-coupled receptor dubbed GPR30 receptor. The present study examines the role of GPR30 versus a classical estrogen receptor (ER) in mediating the growth regulatory effects of estradiol. GPR30 is readily detectable in freshly isolated vascular tissue but barely detectable in cultured vascular smooth muscle cells (VSMC). In freshly isolated aortic tissue, estradiol stimulated extracellular signal-regulated kinases (ERK) phosphorylation. In contrast, in cultured VSMC, where GPR30 expression is significantly reduced, estradiol inhibits ERK phosphorylation. Transfer of the genes encoding GPR30 led to estradiol stimulation of ERK phosphorylation, which is opposite the effects of estradiol in the primary culture of VSMCs. Transduction of the mineralocorticoid receptor (MR) had no effect on estradiol effects on ERK. Estradiol-mediated stimulation of ERK subsequent to heterologous GPR30 expression was pertussis toxin sensitive and phosphoinositide 3-kinase (PI3 kinase) dependent; under these conditions, estradiol also inhibited protein kinase A (PKA). In contrast, in the absence of GPR30 expression in cultured VSMC, estradiol stimulated PKA activity and inhibited ERK phosphorylation. To determine the functional effect of GPR30 (vs. estrogen receptor expression), we assessed estradiol-mediated apoptosis. In the absence of GPR30 expression, estradiol inhibited apoptosis. This effect was enhanced with ER expression. In contrast, with GPR30 expression, estradiol stimulated apoptosis in an ERK-dependent manner. Thus the effect of estradiol on vascular smooth muscle cell apoptosis is likely dependent on the balance between ER-mediated PKA activation and GPR30-mediated PKA inhibition and PI3 kinase activation. Taken together, we postulate that modulation of GPR30 expression or activity may be an important determinant of the effects of estradiol in the vasculature.</p>
]]></description>
<dc:creator><![CDATA[Ding, Q., Gros, R., Limbird, L. E., Chorazyczewski, J., Feldman, R. D.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:45 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00185.2009</dc:identifier>
<dc:title><![CDATA[Estradiol-mediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR 30]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1187</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1178</prism:startingPage>
<prism:section>GROWTH, DIFFERENTIATION, AND APOPTOSIS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1188?rss=1">
<title><![CDATA[Influence of zinc deficiency on Akt-Mdm2-p53 and Akt-p21 signaling axes in normal and malignant human prostate cells]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1188?rss=1</link>
<description><![CDATA[
<p>Phosphorylated Akt (p-Akt), a phosphoinositide-3-OH-kinase-activated protein kinase, is highly expressed in prostate tumors. p-Akt can indirectly hinder p53-dependent growth suppression and apoptosis by phosphorylating Mdm2. Alternatively, p-Akt can directly phosphorylate p21 and restrict it to the cytoplasm for degradation. Because the prostate is the highest zinc-accumulating tissue before the onset of cancer, the effects of physiological levels of zinc on Akt-Mdm2-p53 and Akt-p21 signaling axes in human normal prostate epithelial cells (PrEC) and malignant prostate LNCaP cells were examined in the present study. Cells were cultured for 6 days in low-zinc growth medium supplemented with 0 [zinc-deficient (ZD)], 4 [zinc-normal (ZN)], 16 [zinc-adequate (ZA)], or 32 [zinc-supplemented (ZS)] &micro;M zinc. Zinc status of both cell types was altered in a dose-dependent manner, with LNCaP cells reaching a plateau at &gt;16 &micro;M zinc. For both cell types, p-Akt was higher in the ZD than in the ZN cells and was normalized to that of the ZN cells by treatment with a PI3K inhibitor, LY-294002. PTEN, an endogenous phosphatase targeting Akt dephosphorylation, was hyperphosphorylated (p-PTEN, inactive form) in ZD PrEC. Nuclear p-Mdm2 was raised, whereas nuclear p53 was depressed, by zinc deficiency in PrEC. Nuclear p21 and p53 were lowered by zinc deficiency in LNCaP cells. Higher percentages of ZD, ZA, and ZS than ZN LNCaP cells were found at the G<SUB>0</SUB>/G<SUB>1</SUB> phase of the cell cycle, with proportionally lower precentages at the S and G<SUB>2</SUB>/M phases. Hence, the increased p-PTEN in ZD PrEC would result in hyperphosphorylation of p-Akt and p-Mdm2, as well as reduction of nuclear p53 accumulation. For ZD LNCaP cells, Akt hyperphosphorylation was probably mediated through p21 phosphorylation and degradation, thus restricting p21 nuclear entry to induce cell cycle arrest. Thus zinc deficiency differentially modulated the Akt-Mdm2-p53 signaling axis in normal prostate cells vs. the Akt-p21 signaling axis in malignant prostate cells.</p>
]]></description>
<dc:creator><![CDATA[Han, C.-T., Schoene, N. W., Lei, K. Y.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:45 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00042.2009</dc:identifier>
<dc:title><![CDATA[Influence of zinc deficiency on Akt-Mdm2-p53 and Akt-p21 signaling axes in normal and malignant human prostate cells]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1199</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1188</prism:startingPage>
<prism:section>CELLULAR AND MITOCHONDRIAL METABOLISM</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1200?rss=1">
<title><![CDATA[Molecular regulation of cigarette smoke induced-oxidative stress in human retinal pigment epithelial cells: implications for age-related macular degeneration]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1200?rss=1</link>
<description><![CDATA[
<p>Cigarette smoke is the most important environmental risk factor for developing age-related macular degeneration (AMD). Damage to the retinal pigment epithelium (RPE) caused by cigarette smoke may underlie the etiology of AMD. This study investigated the molecular and cellular effects of cigarette smoke exposure on human RPE cells. ARPE-19 or primary human RPE cells were exposed to cigarette smoke extract (CSE) or hydroquinone (HQ), a component of cigarette smoke. The effect of this exposure on key aspects of RPE vitality including viability, cell size, mitochondrial membrane potential (<SUB>m</SUB>), superoxide production, 4-hydroxy-2-nonenal (4-HNE), vascular endothelial growth factor (VEGF), and heme oxygenase-1 (HO-1) expression was determined. Exposure of RPE cells to CSE or HQ caused oxidative damage and apoptosis, characterized by a reduction in cell size and nuclear condensation. Evidence of oxidative damage also included increased lipid peroxidation (4-HNE) and mitochondrial superoxide production, as well as a decrease in intracellular glutathione (GSH). Exogenous administration of antioxidants (GSH and <I>N</I>-acetyl-cysteine) prevented oxidative damage to the RPE cells caused by CSE. Cigarette smoke also induced expression of VEGF, HO-1, and the transcription factor nuclear factor erythroid-derived 2, like 2 (NRF2). However, NRF2 was only modestly involved in CSE-induced HO-1 expression, as shown by the NRF2 small interfering RNA studies. These new findings demonstrate that cigarette smoke is a potent inducer of oxidative damage and cell death in human RPE cells. These data support the hypothesis that cigarette smoke contributes to AMD pathogenesis by causing oxidative damage and cell death to RPE cells.</p>
]]></description>
<dc:creator><![CDATA[Bertram, K. M., Baglole, C. J., Phipps, R. P., Libby, R. T.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:45 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00126.2009</dc:identifier>
<dc:title><![CDATA[Molecular regulation of cigarette smoke induced-oxidative stress in human retinal pigment epithelial cells: implications for age-related macular degeneration]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1210</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1200</prism:startingPage>
<prism:section>NERVOUS SYSTEM CELL BIOLOGY</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1211?rss=1">
<title><![CDATA[The mechanical behavior of individual sarcomeres of myofibrils isolated from rabbit psoas muscle]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1211?rss=1</link>
<description><![CDATA[
<p>The goal of this study was to develop a system to experiment with sarcomeres mechanically isolated from skeletal muscles. Single myofibrils from rabbit psoas were transferred into a temperature-controlled (22&deg;C or 15&deg;C) experimental chamber, and sarcomeres were isolated using precalibrated glass microneedles that were pierced externally, adjacent to the Z-lines. The force produced during activation was measured by tracking the displacement of the microneedles, and the sarcomere and half-sarcomere changes were measured by continuously tracking the Z-lines and A-bands position during the experiments. Sarcomeres produced a stress (force/cross-sectional area) of 112.75 &plusmn; 4.96 nN/&micro;m<sup>2</sup> (15&deg;C) and 128.47 &plusmn; 5.58 nN/&micro;m<sup>2</sup> (22&deg;C) at lengths between 2.0 &micro;m and 2.4 &micro;m. The descending limb was fitted with linear regression for length between 2.4 &micro;m and 3.5 &micro;m, which provided an abscissa extrapolating to 3.87 &micro;m. The force-length relation was remarkably similar to a theoretical curve based on the degree of filament overlap. During sarcomere activation, we tracked the distance between the center of the A-band and the Z-lines. At lengths below 1.6 &micro;m, movements of A-band were not detected. A-band movements increased with length to achieve a maximum displacement of 59.40 &plusmn; 10.1 nm from the center at 2.0 &micro;m&ndash;2.4 &micro;m. A-band displacement decreased linearly in sarcomere lengths between 2.6 &micro;m and 3.6 &micro;m. A technique for monitoring force and length in single sarcomeres isolated from myofibrils represents a reliable technique to evaluate contractile mechanisms at the most basic, intact level of muscle organization, opening the possibility to clarify long-standing issues in the field of muscle contraction.</p>
]]></description>
<dc:creator><![CDATA[Pavlov, I., Novinger, R., Rassier, D. E.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:45 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00233.2009</dc:identifier>
<dc:title><![CDATA[The mechanical behavior of individual sarcomeres of myofibrils isolated from rabbit psoas muscle]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1219</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1211</prism:startingPage>
<prism:section>METHODS IN CELL PHYSIOLOGY</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1220?rss=1">
<title><![CDATA[Hepatocyte nuclear factor 1 is essential for transcription of sodium-dependent vitamin C transporter protein 1]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1220?rss=1</link>
<description><![CDATA[
<p>Transport and distribution of vitamin C is primarily regulated by the function of sodium-dependent vitamin C transporters (SVCTs). SVCT1 is expressed in the small intestine, liver, and kidney, organs that play a vital role in whole body vitamin C homeostasis. Despite the importance of this protein, little is known about regulation of the gene encoding SVCT1, <I>Slc23a1</I>. In this study, we present the first investigation of the transcriptional regulation of human <I>Slc23a1</I>, identifying transcription factors that may influence its expression. A 1,239-bp genomic DNA fragment corresponding to the 5'-flanking region of <I>Slc23a1</I> was isolated from a human hepatocarcinoma cell line (HepG2) and sequenced. When cloned into a reporter gene construct, robust transcriptional activity was seen in this sequence, nearly 25-fold above the control vector. Deletion analysis of the SVCT1 reporter gene vector defined the minimal active promoter as a small 135-bp region upstream of the transcriptional start site. While several transcription factor binding sites were identified within this sequence, reporter constructs showed that basal transcription required the binding of hepatic nuclear factor 1 (HNF-1) to its cognate sequence. Furthermore, mutation of this HNF-1 binding site resulted in complete loss of luciferase expression, even in the context of the whole promoter. Additionally, small interfering RNA knockdown of both members of the HNF-1 family, HNF-1 and HNF-1&beta;, resulted in a significant decline in SVCT1 transcription. Together, these data suggest that HNF-1 and/or HNF-1&beta; binding is required for SVCT1 expression and may be involved in the coordinate regulation of whole body vitamin C status.</p>
]]></description>
<dc:creator><![CDATA[Michels, A. J., Hagen, T. M.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:45 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00348.2009</dc:identifier>
<dc:title><![CDATA[Hepatocyte nuclear factor 1 is essential for transcription of sodium-dependent vitamin C transporter protein 1]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1227</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1220</prism:startingPage>
<prism:section>MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1228?rss=1">
<title><![CDATA[IL-6 stimulates system A amino acid transporter activity in trophoblast cells through STAT3 and increased expression of SNAT2]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1228?rss=1</link>
<description><![CDATA[
<p>Changes in placental nutrient transport are closely associated with abnormal fetal growth. However, the molecular mechanisms underlying the regulation of placental amino acid transporters are unknown. We demonstrate that physiological concentrations of the proinflammatory cytokines interleukin (IL)-6 and tumor necrosis factor (TNF)- stimulate the activity of amino acid transporter system A, but not system L, in cultured human primary trophoblast cells. Both cytokines increased the gene and protein expression of the Na<sup>+</sup>-coupled neutral amino acid transporter (SNAT)2 isoform and upregulated SNAT1 protein expression. IL-6 increased Tyr705 phosphorylation of signal transducer and activator of transcription 3 (STAT3). In cells transfected with small interfering RNA (siRNA) targeting STAT3, the RNA and protein expression of SNAT2, but not SNAT1, was reduced and the stimulating effect of IL-6 on system A activity was abolished. Despite eliciting similar responses in amino acid transport activity and transporter expression, TNF- effects on system A activity were not mediated through the JAK/STAT pathway. In conclusion, we have identified a novel regulatory pathway involving increased gene expression of the SNAT2 isoform mediated by a STAT-dependent pathway, which links IL-6 to increased activity of system A, a ubiquitously expressed transporter of neutral amino acids. From these new findings, we propose that upregulation of amino acid transporters by cytokines may contribute to increased placental nutrient transport and fetal overgrowth, which are commonly found in pregnancies complicated by maternal diabetes and obesity.</p>
]]></description>
<dc:creator><![CDATA[Jones, H. N., Jansson, T., Powell, T. L.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:45 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00195.2009</dc:identifier>
<dc:title><![CDATA[IL-6 stimulates system A amino acid transporter activity in trophoblast cells through STAT3 and increased expression of SNAT2]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1235</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1228</prism:startingPage>
<prism:section>MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1236?rss=1">
<title><![CDATA[Closed-state inactivation in Kv4.3 isoforms is differentially modulated by protein kinase C]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1236?rss=1</link>
<description><![CDATA[
<p>Kv4.3, with its complex open- and closed-state inactivation (CSI) characteristics, is a primary contributor to early cardiac repolarization. The two alternatively spliced forms, Kv4.3-short (Kv4.3-S) and Kv4.3-long (Kv4.3-L), differ by the presence of a 19-amino acid insert downstream from the sixth transmembrane segment. The isoforms are similar kinetically; however, the longer form has a unique PKC phosphorylation site. To test the possibility that inactivation is differentially regulated by phosphorylation, we expressed the Kv4.3 isoforms in <I>Xenopus</I> oocytes and examined changes in their inactivation properties after stimulation of PKC activity. Whereas there was no difference in open-state inactivation, there were profound differences in CSI. In Kv4.3-S, PMA reduced the magnitude of CSI by 24% after 14.4 s at &ndash;50 mV. In contrast, the magnitude of CSI in Kv4.3-L increased by 25% under the same conditions. Mutation of a putatively phosphorylated threonine (T504) to aspartic acid within a PKC consensus recognition sequence unique to Kv4.3-L eliminated the PMA response. The change in CSI was independent of the intervention used to increase PKC activity; identical results were obtained with either PMA or injected purified PKC. Our previously published 11-state model closely simulated our experimental data. Our data demonstrate isoform-specific regulation of CSI by PKC in Kv4.3 and show that the carboxy terminus of Kv4.3 plays an important role in regulation of CSI.</p>
]]></description>
<dc:creator><![CDATA[Xie, C., Bondarenko, V. E., Morales, M. J., Strauss, H. C.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:45 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00144.2009</dc:identifier>
<dc:title><![CDATA[Closed-state inactivation in Kv4.3 isoforms is differentially modulated by protein kinase C]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1248</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1236</prism:startingPage>
<prism:section>MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1249?rss=1">
<title><![CDATA[17{beta}-Estradiol regulates the first steps of skeletal muscle cell differentiation via ER-{alpha}-mediated signals]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1249?rss=1</link>
<description><![CDATA[
<p>17&beta;-Estradiol (E<SUB>2</SUB>) mediates a wide variety of complex biological processes determining the growth and development of reproductive tract as well as nonreproductive tissues of male and female individuals. While E<SUB>2</SUB> effects on the reproductive system, bone, and cardiovascular system are quite well established, less is known about how it affects the physiology of other tissues. Skeletal muscle is a tissue that is expected to be E<SUB>2</SUB> responsive since both isoforms of estrogen receptor (ER- and ER-&beta;) are expressed. Significant sex-related differences have been described in skeletal muscle, although the role played by E<SUB>2</SUB> and the mechanisms underlying it remain to be determined. Here, we demonstrate that E<SUB>2</SUB> increases the glucose transporter type 4 translocation at membranes as well as the expression of well-known differentiation markers of myogenesis (i.e., myogenin and myosin heavy chain) in rat myoblast cells (L6). These E<SUB>2</SUB>-induced effects require rapid extranuclear signals and the presence of ER-, whereas no contribution of IGF-I receptor has been observed. In particular, ER--dependent Akt activation participates in regulating the first step of myogenic differentiation. Moreover, both receptors mediate the E<SUB>2</SUB>-induced activation of p38, which, in turn, affects the expression of myogenin and myosin heavy chain. All together, these data indicate that E<SUB>2</SUB> should be included in the list of skeletal muscle trophic factors.</p>
]]></description>
<dc:creator><![CDATA[Galluzzo, P., Rastelli, C., Bulzomi, P., Acconcia, F., Pallottini, V., Marino, M.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:45 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00188.2009</dc:identifier>
<dc:title><![CDATA[17{beta}-Estradiol regulates the first steps of skeletal muscle cell differentiation via ER-{alpha}-mediated signals]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1262</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1249</prism:startingPage>
<prism:section>RECEPTORS AND SIGNAL TRANSDUCTION</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1263?rss=1">
<title><![CDATA[Transforming growth factor-{beta}1 downregulates caveolin-1 expression and enhances sphingosine 1-phosphate signaling in cultured vascular endothelial cells]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1263?rss=1</link>
<description><![CDATA[
<p>In vascular endothelial cells, specialized microdomains of plasma membrane termed caveolae modulate various receptor signal transduction pathways regulated by caveolin-1, a resident protein of caveolae. We examined whether transforming growth factor-&beta;1 (TGF-&beta;1), a multifunctional cytokine, alters expression levels of caveolin-1 and influences heterologous receptor signaling. Treatment of cultured bovine aortic endothelial cells (BAEC) with TGF-&beta;1 induces marked decreases in caveolin-1 expression in a time- and dose-dependent fashion at both levels of protein and mRNA. A pharmacological inhibitor of activin receptor-like kinase 5 (ALK-5) counteracts caveolin-1 downregulation by TGF-&beta;1, indicating the involvement of ALK-5 receptor subtype for TGF-&beta;1. Sphingosine 1-phosphate (S1P) is a serum-borne angiogenic lipid growth factor that exerts a wide variety of biological actions. S1P modulates G protein-coupled S1P receptors, activating downstream molecules kinases AMP-activated protein kinase (AMPK), and Akt as well as a small G protein Rac1, ultimately to promote migration. Because S1P receptor signaling is associated with caveolae/caveolin-1, we examined whether pretreatment with TGF-&beta;1 enhances effects of S1P on BAEC. Whereas S1P alone evokes robust BAEC responses to S1P, pretreatment with TGF-&beta;1 leads to even higher magnitudes of S1P-elicited signaling responses and cell migration. Conversely, genetic knockdown of caveolin-1 using small interfering RNA mimics TGF-&beta;1-induced promotion of BAEC responses to S1P. Collectively, these data demonstrate that TGF-&beta;1 downregulates caveolin-1 of cultured endothelial cells, involving ALK-5 receptor subtype. Because downregulation of caveolin-1 by TGF-&beta;1 promotes subsequent heterologous receptor signaling by S1P, these results may also identify novel point of cross-talk between cytokines and sphingolipids within endothelial signal transduction machineries.</p>
]]></description>
<dc:creator><![CDATA[Igarashi, J., Shoji, K., Hashimoto, T., Moriue, T., Yoneda, K., Takamura, T., Yamashita, T., Kubota, Y., Kosaka, H.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:45 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00109.2009</dc:identifier>
<dc:title><![CDATA[Transforming growth factor-{beta}1 downregulates caveolin-1 expression and enhances sphingosine 1-phosphate signaling in cultured vascular endothelial cells]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1274</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1263</prism:startingPage>
<prism:section>RECEPTORS AND SIGNAL TRANSDUCTION</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1275?rss=1">
<title><![CDATA[Mind bomb 1 regulation of cFLIP interactions]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1275?rss=1</link>
<description><![CDATA[
<p>Mind bomb 1 (Mib1) is a multidomain E3 ligase that directs ubiquitination of the Notch ligands Delta and Jagged to promote their endocytosis. Here we examine Notch-independent functions of Mib1 and find that its activities are linked to the initiation of the extrinsic cell death pathway. Expression of Mib1 induces a spontaneous, caspase-dependent cell death. Consistent with this, depletion of endogenous Mib1 decreases tumor-necrosis factor (TNF)-induced cell death. Mib1 was found to bind to cellular Fas-associated death domain (FADD)-like IL-1b converting enzyme (FLICE)-like inhibitory proteins (cFLIP-L and cFLIP-S), whereas only cFLIP-s can inhibit Mib1-induced cell death. The interaction between Mib1 and cFLIP decreases the association of caspase-8 with cFLIP, which activates caspase-8 and induces cell death. Collectively, these results suggest that in addition to a central role in Notch signaling, Mib1 has an important role in regulating the extrinsic cell death pathway.</p>
]]></description>
<dc:creator><![CDATA[Zhang, L., Gallagher, P. J.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:45 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00214.2009</dc:identifier>
<dc:title><![CDATA[Mind bomb 1 regulation of cFLIP interactions]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1283</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1275</prism:startingPage>
<prism:section>RECEPTORS AND SIGNAL TRANSDUCTION</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1284?rss=1">
<title><![CDATA[MEK, p38, and PI-3K mediate cross talk between EGFR and TNFR in enhancing hepatocyte growth factor production from human mesenchymal stem cells]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1284?rss=1</link>
<description><![CDATA[
<p>Human bone marrow mesenchymal stem cells (MSCs) are a potent source of growth factors, which are partly responsible for their beneficial paracrine effects. We reported previously that transforming growth factor- (TGF-), a putative mediator of wound healing and the injury response, increases the release of vascular endothelial growth factor (VEGF), augments tumor necrosis factor- (TNF-)-stimulated VEGF production, and activates mitogen-activated protein kinases and phosphatidylinositol 3-kinase (PI-3K) pathway in human MSCs. The experiments described in this report indicate that TGF- increases MSC-derived hepatocyte growth factor (HGF) production. TGF--stimulated HGF production was abolished by inhibition of MEK, p38, PI-3K, or by small interfering RNA (siRNA) targeting TNF receptor 2 (TNFR2), but was not attenuated by siRNA targeting TNF receptor 1 (TNFR1). Ablation of TNFR1 significantly increased basal and stimulated HGF. A potent synergy between TGF- and TNF- was noted in MSC HGF production. This synergistic effect was abolished by MEK, P38, PI-3K inhibition, or by ablation of both TNF receptors using siRNA. We conclude that <I>1</I>) novel cross talk occurs between tumor necrosis factor receptor and TGF-/epidermal growth factor receptor in stimulating MSC HGF production; <I>2</I>) this cross talk is mediated, at least partially, via activation of MEK, p38, and PI-3K; <I>3</I>) TGF- stimulates MSCs to produce HGF by MEK, p38, PI-3K, and TNFR2-dependent mechanisms; and <I>4</I>) TNFR1 acts to decrease basal TGF- and TNF--stimulated HGF.</p>
]]></description>
<dc:creator><![CDATA[Wang, Y., Weil, B. R., Herrmann, J. L., Abarbanell, A. M., Tan, J., Markel, T. A., Kelly, M. L., Meldrum, D. R.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:45 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00183.2009</dc:identifier>
<dc:title><![CDATA[MEK, p38, and PI-3K mediate cross talk between EGFR and TNFR in enhancing hepatocyte growth factor production from human mesenchymal stem cells]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1293</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1284</prism:startingPage>
<prism:section>RECEPTORS AND SIGNAL TRANSDUCTION</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1294?rss=1">
<title><![CDATA[Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1294?rss=1</link>
<description><![CDATA[
<p>The cholinergic anti-inflammatory pathway is a physiological mechanism that inhibits cytokine production and minimizes tissue injury during inflammation. Previous investigations revealed that cholinergic stimulation (via cholinergic agonists and vagus nerve stimulation) suppresses endothelial cell activation and leukocyte recruitment. The purpose of this study was to investigate the mechanisms by which cholinergic agonists (e.g., nicotine and GTS-21) regulate endothelial cell activation. Specifically, we examined the effects of cholinergic agonists on IL-6-mediated endothelial cell activation through the JAK2/STAT3 signaling pathway. Treatment of macrovascular human umbilical vein endothelial cells (HUVECs) and microvascular endothelial cells (MVECs) with the cholinergic agonists nicotine and GTS-21 significantly reduced IL-6-mediated monocyte chemoattractant protein-1 (MCP-1) production and ICAM-1 expression which are regulated through the JAK2/STAT3 pathway. We found that treatment of endothelial cells with cholinergic agonists significantly reduced STAT3 activation by phosphorylation and DNA binding. The inhibition of STAT3 phosphorylation was reversed by sodium orthovanadate, an inhibitor of tyrosine phosphatases, as well as by NSC-87877 suggesting a SHP1/2-dependent mechanism. Further investigations showed that cholinergic agonists reduced the phosphorylation of JAK2, an upstream component of the JAK2/STAT3 pathway. Finally, we observed that nicotine and GTS-21 treatment decreased levels of SOCS3 (suppressor of cytokine signaling; a regulator of the inflammatory activity of IL-6) in activated endothelial cells. These data demonstrate that cholinergic agonists suppress IL-6-mediated endothelial cell activation through the JAK2/STAT3 pathway. Our results have significant implications for better understanding the therapeutic potential of cholinergic agonists for treating IL-6 mediated inflammatory conditions.</p>
]]></description>
<dc:creator><![CDATA[Chatterjee, P. K., Al-Abed, Y., Sherry, B., Metz, C. N.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:45 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00160.2009</dc:identifier>
<dc:title><![CDATA[Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1306</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1294</prism:startingPage>
<prism:section>VASCULAR BIOLOGY</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1307?rss=1">
<title><![CDATA[Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and Type 2 diabetic patients]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1307?rss=1</link>
<description><![CDATA[
<p>Individuals with Type 2 diabetes mellitus (T2DM) are at increased risk of saphenous vein (SV) graft stenosis following coronary artery bypass. Graft stenosis is caused by intimal hyperplasia, a pathology characterized by smooth muscle cell (SMC) proliferation and migration. We hypothesized that SV-SMC from T2DM patients were intrinsically more proliferative and migratory than those from nondiabetic individuals. SV-SMC were cultured from nondiabetic and T2DM patients. Cell morphology (light microscopy, immunocytochemistry), S100A4 expression (real-time RT-PCR, immunoblotting), proliferation (cell counting), migration (Boyden chamber assay), and cell signaling (immunoblotting with phosphorylation state-specific antibodies) were studied. SV-SMC from T2DM patients were morphologically distinct from nondiabetic patients and exhibited a predominantly rhomboid phenotype, accompanied by disrupted F-actin cytoskeleton, disorganized -smooth muscle actin network, and increased focal adhesion formation. However, no differences were observed in expression of the calcium-binding protein S100A4, a marker of rhomboid SMC phenotype, between the two cell populations. T2DM cells were less proliferative in response to fetal calf serum than nondiabetic cells, but both populations had similar proliferative responses to insulin plus PDGF. Under high glucose concentration conditions in the presence of insulin, migration of diabetic SV-SMC was greater than nondiabetic cells. Glucose concentration did not affect SV-SMC proliferation. No differences in insulin or PDGF-induced phosphorylation of ERK-1/2 or components of the Akt pathway (Akt-Ser473, Akt-Thr308, and GSK-3&beta;) were apparent between the two populations. In conclusion, SV-SMC from T2DM patients differ from nondiabetic SV-SMC in that they exhibit a rhomboid phenotype and are more migratory, but less proliferative, in response to serum.</p>
]]></description>
<dc:creator><![CDATA[Madi, H. A., Riches, K., Warburton, P., O'Regan, D. J., Turner, N. A., Porter, K. E.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:45 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00608.2008</dc:identifier>
<dc:title><![CDATA[Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and Type 2 diabetic patients]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1317</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1307</prism:startingPage>
<prism:section>VASCULAR BIOLOGY</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1318?rss=1">
<title><![CDATA[Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor {alpha}-converting enzyme]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/5/C1318?rss=1</link>
<description><![CDATA[
<p>Angiotensin-converting enzyme 2 (ACE2) is a newly identified regulator of the renin-angiotensin system. This type I membrane-anchored protein has a catalytically active ectodomain that undergoes shedding. Tumor necrosis factor -converting enzyme (TACE) has been shown to be involved in ACE2 shedding. Although pathophysiological significance of ACE2 shedding has been suggested, regulation of this process by TACE is not clearly defined. We characterized TACE-mediated constitutive ectodomain shedding of ACE2 using wild-type Chinese Hamster Ovary (WT-CHO), the TACE-mutant M2 (M2-CHO) cells, and EC-4 and EC-2 cells that are fibroblasts from wild-type and TACE-null mice, respectively. ACE2 was constitutively cleaved to release two distinct major soluble forms. The deglycosylated molecular masses of the larger (LSF) and smaller soluble form (SSF) were ~80 and 70 kDa, respectively. These forms had equivalent enzyme activities. Reduced shedding for the LSF from M2-CHO and EC-2 cells when compared with WT-CHO and EC-4 cells, respectively, was noted. TACE reconstitution in EC-2 cells expressing ACE2 resulted in increase in LSF but not SSF release, demonstrating a main role of TACE in LSF release and distinct regulations of release of the two soluble forms. Deletions of the juxtamembrane region of ACE2 reduced LSF release in CHO cell lines, whereas it abolished TACE-induced shedding in EC-2 cells. Analysis of TACE structural domains confirmed that the active site in the catalytic domain is essential for ACE2 shedding but that noncatalytic domains also play additional roles. These results demonstrate selective and specific regulation of constitutive shedding of ACE2 by TACE.</p>
]]></description>
<dc:creator><![CDATA[Iwata, M., Silva Enciso, J. E., Greenberg, B. H.]]></dc:creator>
<dc:date>Wed, 28 Oct 2009 17:34:45 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00036.2009</dc:identifier>
<dc:title><![CDATA[Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor {alpha}-converting enzyme]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1329</prism:endingPage>
<prism:publicationDate>2009-11-01</prism:publicationDate>
<prism:startingPage>C1318</prism:startingPage>
<prism:section>CELLULAR AND MITOCHONDRIAL METABOLISM</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/full/297/4/C797?rss=1">
<title><![CDATA[Epac in melanoma: a contributor to tumor cell physiology? Focus on "Epac increases melanoma cell migration by a heparin sulfate-related mechanism"]]></title>
<link>http://ajpcell.physiology.org/cgi/content/full/297/4/C797?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Lezoualc'h, F.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00358.2009</dc:identifier>
<dc:title><![CDATA[Epac in melanoma: a contributor to tumor cell physiology? Focus on "Epac increases melanoma cell migration by a heparin sulfate-related mechanism"]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C799</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C797</prism:startingPage>
<prism:section>EDITORIAL FOCUS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/full/297/4/C800?rss=1">
<title><![CDATA[Focal adhesion kinase phosphorylation in flow-activation of endothelial NF-{kappa}B. Focus on "Focal adhesion kinase modulates activation of NF-{kappa}B by flow in endothelial cells"]]></title>
<link>http://ajpcell.physiology.org/cgi/content/full/297/4/C800?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Chien, S., Chiu, J.-J., Li, Y.-S.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00364.2009</dc:identifier>
<dc:title><![CDATA[Focal adhesion kinase phosphorylation in flow-activation of endothelial NF-{kappa}B. Focus on "Focal adhesion kinase modulates activation of NF-{kappa}B by flow in endothelial cells"]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C801</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C800</prism:startingPage>
<prism:section>EDITORIAL FOCUS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C802?rss=1">
<title><![CDATA[Epac increases melanoma cell migration by a heparan sulfate-related mechanism]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C802?rss=1</link>
<description><![CDATA[
<p>Melanoma, the most malignant form of human skin cancer, has a poor prognosis due to its strong metastatic ability. It was recently demonstrated that Epac, an effector molecule of cAMP, is involved in regulating cell migration; however, the role of Epac in melanoma cell migration remains unclear. We thus examined whether Epac regulates cell migration and metastasis of melanoma. Epac activation, by either specific agonist or overexpression of Epac, increased melanoma cell migration. Deletion of endogenous Epac with small interfering RNA decreased basal melanoma cell migration. These data suggested a major role of Epac in melanoma cell migration. Epac-induced cell migration was mediated by translocation of syndecan-2, a cell-surface heparan sulfate proteoglycan, to lipid rafts. This syndecan-2 translocation was regulated by tubulin polymerization via the Epac/phosphoinositol-3 kinase pathway. Epac-induced cell migration was also regulated by the production of heparan sulfate, a major extracellular matrix. Epac-induced heparan sulfate production was attributable to the increased expression of <I>N</I>-deacetylase/<I>N</I>-sulfotransferase-1 (NDST-1) accompanied by an increased NDST-1 translation rate. Finally, Epac overexpression enhanced lung colonization of melanoma cells in mice. Taken together, these data indicate that Epac regulates melanoma cell migration/metastasis mostly via syndecan-2 translocation and heparan sulfate production.</p>
]]></description>
<dc:creator><![CDATA[Baljinnyam, E., Iwatsubo, K., Kurotani, R., Wang, X., Ulucan, C., Iwatsubo, M., Lagunoff, D., Ishikawa, Y.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00129.2009</dc:identifier>
<dc:title><![CDATA[Epac increases melanoma cell migration by a heparan sulfate-related mechanism]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C813</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C802</prism:startingPage>
<prism:section>RECEPTORS AND SIGNAL TRANSDUCTION</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C814?rss=1">
<title><![CDATA[Focal adhesion kinase modulates activation of NF-{kappa}B by flow in endothelial cells]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C814?rss=1</link>
<description><![CDATA[
<p>Atherogenesis involves activation of NF-B in endothelial cells by fluid shear stress. Because this pathway involves integrins, we investigated the involvement of focal adhesion kinase (FAK). We found that FAK was not required for flow-stimulated translocation of the p65 NF-B subunit to the nucleus but was essential for phosphorylation of p65 on serine 536 and induction of ICAM-1, an NF-B-dependent gene. NF-B activation by TNF- or hydrogen peroxide was FAK independent. Events upstream of NF-B, including integrin activation, Rac activation, reactive oxygen production, and degradation of IB, were FAK independent. FAK therefore regulates NF-B phosphorylation and transcriptional activity in response to flow by a novel mechanism.</p>
]]></description>
<dc:creator><![CDATA[Petzold, T., Orr, A. W., Hahn, C., Jhaveri, K. A., Parsons, J. T., Schwartz, M. A.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00226.2009</dc:identifier>
<dc:title><![CDATA[Focal adhesion kinase modulates activation of NF-{kappa}B by flow in endothelial cells]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C822</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C814</prism:startingPage>
<prism:section>VASCULAR BIOLOGY</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C823?rss=1">
<title><![CDATA[Membrane trauma and Na+ leak from Nav1.6 channels]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C823?rss=1</link>
<description><![CDATA[
<p>During brain trauma, white matter experiences shear and stretch forces that, without severing axons, nevertheless trigger their secondary degeneration. In central nervous system (CNS) trauma models, voltage-gated sodium channel (Nav) blockers are neuroprotective. This, plus the rapid tetrodotoxin-sensitive Ca<sup>2+</sup> overload of stretch-traumatized axons, points to "leaky" Nav channels as a pivotal early lesion in brain trauma. Direct effects of mechanical trauma on neuronal Nav channels have not, however, been tested. Here, we monitor immediate responses of recombinant neuronal Nav channels to stretch, using patch-clamp and Na<sup>+</sup>-dye approaches. Trauma constituted either bleb-inducing aspiration of cell-attached oocyte patches or abrupt uniaxial stretch of cells on an extensible substrate. Nav1.6 channel transient current displayed irreversible hyperpolarizing shifts of steady-state inactivation [availability(V)] and of activation [<I>g</I>(V)] and, thus, of window current. Left shift increased progressively with trauma intensity. For moderately intense patch trauma, a ~20-mV hyperpolarizing shift was registered. Nav1.6 voltage sensors evidently see lower energy barriers posttrauma, probably because of the different bilayer mechanics of blebbed versus intact membrane. Na<sup>+</sup> dye-loaded human embryonic kidney (HEK) cells stably transfected with Nav1.6 were subjected to traumatic brain injury-like stretch. Cytoplasmic Na<sup>+</sup> levels abruptly increased and the trauma-induced influx had a significant tetrodotoxin-sensitive component. Nav1.6 channel responses to cell and membrane trauma are therefore consistent with the hypothesis that mechanically induced Nav channel leak is a primary lesion in traumatic brain injury. Nav1.6 is the CNS node of Ranvier Nav isoform. When, during head trauma, nodes experienced bleb-inducing membrane damage of varying intensities, nodal Nav1.6 channels should immediately "leak" over a broadly left-smeared window current range.</p>
]]></description>
<dc:creator><![CDATA[Wang, J. A., Lin, W., Morris, T., Banderali, U., Juranka, P. F., Morris, C. E.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00505.2008</dc:identifier>
<dc:title><![CDATA[Membrane trauma and Na+ leak from Nav1.6 channels]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C834</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C823</prism:startingPage>
<prism:section>MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C835?rss=1">
<title><![CDATA[PKC induces internalization and retention of the EAAC1 glutamate transporter in recycling endosomes of MDCK cells]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C835?rss=1</link>
<description><![CDATA[
<p>Here we show that stimulation of protein kinase C (PKC) by phorbol 12-myristate 13-acetate (PMA) treatment induces a time-dependent decrease in glutamate transport activity due to relocalization of the excitatory amino acid carrier 1 (EAAC1) glutamate transporter from the apical surface of polarized epithelial Madin-Darby canine kidney (MDCK) cells to intracellular compartments. The PKC-induced internalization of EAAC1 is negatively regulated by the calcineurin inhibitor cyclosporine A and by the expression of a dominant-negative mutant of the endocytic protein dynamin 1, a well-known target of the phosphatase activity of calcineurin. Using <sup>32</sup>P-metabolic labeling experiments, we found unchanged levels of phosphorylated EAAC1, indicating that EAAC1 relocalization does not depend on PKC and calcineurin modification of the transporter, while we found that a target of these modifications was the serine<sup>778</sup> residue of dynamin, a calcineurin substrate that in its dephosphorylated form activates the endocytic functions of dynamin. These data suggest that PMA stimulates endogenous dynamin and that this activation is required to mediate internalization of EAAC1 in MDCK cells. By immunofluorescence experiments with endosomal markers we demonstrated that internalized EAAC1 accumulates in endosomes also containing the basolateral betaine-GABA transporter BGT1 and activated PKC. The sustained activation of PKC was required to maintain the transporters in the endosomal compartment, while a posttreatment with a PKC-specific inhibitor induced the recycling of the transporters to their appropriate surfaces. Taken together, our data indicate that PKC activity regulates EAAC1 surface density in MDCK cells by inducing its internalization and retention in PKC-labeled recycling endosomes common to apical and basolateral proteins.</p>
]]></description>
<dc:creator><![CDATA[Padovano, V., Massari, S., Mazzucchelli, S., Pietrini, G.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00212.2009</dc:identifier>
<dc:title><![CDATA[PKC induces internalization and retention of the EAAC1 glutamate transporter in recycling endosomes of MDCK cells]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C844</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C835</prism:startingPage>
<prism:section>MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C845?rss=1">
<title><![CDATA[Chloride transport in mitochondrion-rich cells of euryhaline tilapia (Oreochromis mossambicus) larvae]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C845?rss=1</link>
<description><![CDATA[
<p>A noninvasive scanning ion-selective electrode technique (SIET) was applied to measure Cl<sup>&ndash;</sup> transport at individual mitochondrion-rich cells (MRCs) in the skin of euryhaline tilapia (<I>Oreochromis mossambicus</I>) larvae. In seawater (SW)-acclimated larvae, outward Cl<sup>&ndash;</sup> gradients (20~80 mM higher than the background) were measured at the surface, indicating a secretion of Cl<sup>&ndash;</sup> from the skin. By serial probing over the surface of MRCs and adjacent keratinocytes (KCs), a significant outward flux of Cl<sup>&ndash;</sup> was detected at the apical opening (membrane) of MRCs. Treatment with 100 &micro;M ouabain or bumetanide inhibited the Cl<sup>&ndash;</sup> secretion by ~75%. In freshwater (FW)-acclimated larvae, a lower level of outward Cl<sup>&ndash;</sup> gradients (0.2~1 mM) was measured at the skin surface. Low-Cl<sup>&ndash;</sup> water (&lt;0.005 mM) acclimation increased the apical Na<sup>+</sup>-Cl<sup>&ndash;</sup> cotransporter (NCC) immunoreactivity of MRCs in the larval skin. An inward flux of Cl<sup>&ndash;</sup> was detected when probing the exterior surface of a group of MRCs (convex-MRCs) that express the NCC. An NCC inhibitor (100 &micro;M metolazone) reduced the flux by ~90%. This study provides direct and convincing evidence for Cl<sup>&ndash;</sup> transport by MRCs of SW- and FW-acclimated euryhaline tilapia and the involvement of an apical NCC in Cl<sup>&ndash;</sup> uptake of MRCs of FW-acclimated fish.</p>
]]></description>
<dc:creator><![CDATA[Horng, J.-L., Hwang, P.-P., Shih, T.-H., Wen, Z.-H., Lin, C.-S., Lin, L.-Y.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00218.2009</dc:identifier>
<dc:title><![CDATA[Chloride transport in mitochondrion-rich cells of euryhaline tilapia (Oreochromis mossambicus) larvae]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C854</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C845</prism:startingPage>
<prism:section>MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C855?rss=1">
<title><![CDATA[Identification of subdomains in NADPH oxidase-4 critical for the oxygen-dependent regulation of TASK-1 K+ channels]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C855?rss=1</link>
<description><![CDATA[
<p>Hypoxic inhibition of K<sup>+</sup> current is a critical O<SUB>2</SUB>-sensing mechanism. Previously, it was demonstrated that the cooperative action of TASK-1 and NADPH oxidase-4 (NOX4) mediated the O<SUB>2</SUB>-sensitive K<sup>+</sup> current response. Here we addressed the O<SUB>2</SUB>-sensing mechanism of NOX4 in terms of TASK-1 regulation. In TASK-1 and NOX4-coexpressing human embryonic kidney 293 cells, hypoxia (5% O<SUB>2</SUB>) decreased the amplitude of TASK-1 current (hypoxia-<I>I</I><SUB>TASK-1</SUB>). To examine whether reactive oxygen species (ROS) mediate the hypoxia-<I>I</I><SUB>TASK-1</SUB>, we treated the cells with carbon monoxide (CO) which is known to reduce ROS generation from the heme-containing NOX4. Unexpectedly, CO failed to mimic hypoxia in TASK-1 regulation, rather blocked the hypoxia-<I>I</I><SUB>TASK-1</SUB>. Moreover, the hypoxia-<I>I</I><SUB>TASK-1</SUB> was neither recovered by H<SUB>2</SUB>O<SUB>2</SUB> treatment nor prevented by antioxidant such as ascorbic acid. However, the hypoxia-<I>I</I><SUB>TASK-1</SUB> was noticeably attenuated by succinyl acetone, a heme synthase inhibitor. To further evaluate the role of heme, we constructed and expressed various NOX4 mutants, such as HBD(&ndash;) lacking the heme binding domain, NBD(&ndash;) lacking the NADPH binding domain, FBD(&ndash;) lacking the FAD binding domain, and HFBD(&ndash;) lacking both heme and FAD domains. The hypoxia-<I>I</I><SUB>TASK-1</SUB> was significantly reduced in HBD(&ndash;)-, FBD(&ndash;)-, or HFBD(&ndash;)-expressing cells, versus wild-type NOX4-expressing cells. However, NBD(&ndash;) did not affect the TASK-1 response to hypoxia. We also found that p22 is required for the NOX4-dependent TASK-1 regulation. These results suggest that O<SUB>2</SUB> binding with NOX4 per se controls TASK-1 activity. In this process, the heme moiety and FBD seem to be responsible for the NOX4 regulation of TASK-1, and p22 might support the NOX4-TASK-1 interaction.</p>
]]></description>
<dc:creator><![CDATA[Park, S. J., Chun, Y.-S., Park, K. S., Kim, S. J., Choi, S.-O., Kim, H.-L., Park, J.-W.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00463.2008</dc:identifier>
<dc:title><![CDATA[Identification of subdomains in NADPH oxidase-4 critical for the oxygen-dependent regulation of TASK-1 K+ channels]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C864</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C855</prism:startingPage>
<prism:section>MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C865?rss=1">
<title><![CDATA[Cloning, localization, and functional expression of the electrogenic Na+ bicarbonate cotransporter (NBCe1) from zebrafish]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C865?rss=1</link>
<description><![CDATA[
<p>Mutations in the electrogenic Na<sup>+</sup>/<I>n</I>HCO<SUB>3</SUB><sup>&ndash;</sup> cotransporter (NBCe1, SLC4A4) cause severe proximal renal tubular acidosis, glaucoma, and cataracts in humans, indicating NBCe1 has a critical role in acid-base homeostasis and ocular fluid transport. To better understand the homeostatic roles and protein ontogeny of NBCe1, we have cloned, localized, and downregulated NBCe1 expression in zebrafish, and examined its transport characteristics when expressed in <I>Xenopus</I> oocytes. Zebrafish NBCe1 (zNBCe1) is 80% identical to published mammalian NBCe1 cDNAs. Like other fish NBCe1 clones, zebrafish NBCe1 is most similar to the pancreatic form of mammalian NBC (Slc4a4-B) but appears to be the dominant isoform found in zebrafish. In situ hybridization of embryos demonstrated mRNA expression in kidney pronephros and eye by 24 h postfertilization (hpf) and gill and brain by 120 hpf. Immunohistochemical labeling demonstrated expression in adult zebrafish eye and gill. Morpholino knockdown studies demonstrated roles in eye and brain development and caused edema, indicating altered fluid and electrolyte balance. With the use of microelectrodes to measure membrane potential (<I>V</I><SUB>m</SUB>), voltage clamp (VC), intracellular pH (pH<SUB>i</SUB>), or intracellular Na<sup>+</sup> activity (<I>a</I>Na<SUB>i</SUB>), we examined the function of zNBCe1 expressed in <I>Xenopus</I> oocytes. Zebrafish NBCe1 shared transport properties with mammalian NBCe1s, demonstrating electrogenic Na<sup>+</sup> and HCO<f><SUB>3</SUB></f><sup>&ndash;</sup> transport as well as similar drug sensitivity, including inhibition by 4,4'-diiso-thiocyano-2,2'-disulfonic acid stilbene and tenidap. These data indicate that NBCe1 in zebrafish shares many characteristics with mammalian NBCe1, including tissue distribution, importance in systemic water and electrolyte balance, and electrogenic transport of Na<sup>+</sup> and HCO<f><SUB>3</SUB></f><sup>&ndash;</sup>. Thus zebrafish promise to be useful model system for studies of NBCe1 physiology.</p>
]]></description>
<dc:creator><![CDATA[Sussman, C. R., Zhao, J., Plata, C., Lu, J., Daly, C., Angle, N., DiPiero, J., Drummond, I. A., Liang, J. O., Boron, W. F., Romero, M. F., Chang, M.-H.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00679.2008</dc:identifier>
<dc:title><![CDATA[Cloning, localization, and functional expression of the electrogenic Na+ bicarbonate cotransporter (NBCe1) from zebrafish]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C875</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C865</prism:startingPage>
<prism:section>MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C876?rss=1">
<title><![CDATA[Mechanisms underlying Andersen's syndrome pathology in skeletal muscle are revealed in human myotubes]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C876?rss=1</link>
<description><![CDATA[
<p>Andersen's syndrome is a rare disorder that has been defined with a triad: periodic paralysis, cardiac arrhythmia, and development anomalies. Muscle weakness has been reported in two-thirds of the patients. <I>KCNJ2</I> remains the only gene linked to Andersen's syndrome; this gene encodes for the -subunit of the strong inward-rectifier K<sup>+</sup> channel Kir2.1. Several studies have shown that Andersen's syndrome mutations lead to a loss of function of the K<sup>+</sup> channel activity in vitro. However, ex vivo studies on isolated patient muscle tissue have not been reported. We have performed muscle biopsies of controls and patients presenting with clinically and genetically defined Andersen's syndrome disorder. Myoblasts were cultured and characterized morphologically and functionally using the whole cell patch-clamp technique. No morphological difference was observed between Andersen's syndrome and control myoblasts at each passage of the cell culture. Cellular proliferation and viability were quantified in parallel with direct cell counts and showed no difference between control and Andersen's syndrome patients. Moreover, our data show no significant difference in myoblast fusion index among Andersen's syndrome and control patients. Current recordings carried out on myotubes revealed the absence of an inwardly rectifying Ba<sup>2+</sup>-sensitive current in affected patient cells. One consequence of the Ik1 current loss in Andersen's syndrome myotubes is a shift of the resting membrane potential toward depolarizing potentials. Our data describe for the first time the functional consequences of Andersen's syndrome mutations ex vivo and provide clues to the K<sup>+</sup> channel pathophysiology in skeletal muscle.</p>
]]></description>
<dc:creator><![CDATA[Sacconi, S., Simkin, D., Arrighi, N., Chapon, F., Larroque, M. M., Vicart, S., Sternberg, D., Fontaine, B., Barhanin, J., Desnuelle, C., Bendahhou, S.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00519.2008</dc:identifier>
<dc:title><![CDATA[Mechanisms underlying Andersen's syndrome pathology in skeletal muscle are revealed in human myotubes]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C885</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C876</prism:startingPage>
<prism:section>MUSCLE CELL BIOLOGY AND CELL MOTILITY</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C886?rss=1">
<title><![CDATA[Amantadine inhibits platelet-activating factor induced clathrin-mediated endocytosis in human neutrophils]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C886?rss=1</link>
<description><![CDATA[
<p>Receptor signaling is integral for adhesion, emigration, phagocytosis, and reactive oxygen species production in polymorphonuclear neutrophils (PMNs). Priming is an important part of PMN emigration, but it can also lead to PMN-mediated organ injury in the host. Platelet-activating factor (PAF) primes PMNs through activation of a specific G protein-coupled receptor. We hypothesize that PAF priming of PMNs requires clathrin-mediated endocytosis (CME) of the PAF receptor (PAFr), and, therefore, amantadine, known to inhibit CME, significantly antagonizes PAF signaling. PMNs were isolated by standard techniques to &gt;98% purity and tested for viability. Amantadine (1 mM) significantly inhibited the PAF-mediated changes in the cellular distribution of clathrin and the physical colocalization [fluorescence resonance energy transfer positive (FRET<sup>+</sup>)] of early endosome antigen-1 and Rab5a, known components of CME and similar to hypertonic saline, a known inhibitor of CME. Furthermore, amantadine had no effect on the PAF-induced cytosolic calcium flux; however, phosphorylation of p38 MAPK was significantly decreased. Amantadine inhibited PAF-mediated changes in PMN physiology, including priming of the NADPH oxidase and shape change with lesser inhibition of increases in CD11b surface expression and elastase release. Furthermore, rimantadine, an amantadine analog, was a more potent inhibitor of PAF priming of the <I>N</I>-formyl-methionyl-leucyl-phenylalanine-activated oxidase. PAF priming of PMNs requires clathrin-mediated endocytosis that is inhibited when PMNs are pretreated with either amantadine or rimantadine. Thus, amantadine and rimantadine have the potential to ameliorate PMN-mediated tissue damage in humans.</p>
]]></description>
<dc:creator><![CDATA[Eckels, P. C., Banerjee, A., Moore, E. E., McLaughlin, N. J. D., Gries, L. M., Kelher, M. R., England, K. M., Gamboni-Robertson, F., Khan, S. Y., Silliman, C. C.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00416.2008</dc:identifier>
<dc:title><![CDATA[Amantadine inhibits platelet-activating factor induced clathrin-mediated endocytosis in human neutrophils]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C897</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C886</prism:startingPage>
<prism:section>RECEPTORS AND SIGNAL TRANSDUCTION</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C898?rss=1">
<title><![CDATA[Hyperosmolarity regulates SOX9 mRNA posttranscriptionally in human articular chondrocytes]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C898?rss=1</link>
<description><![CDATA[
<p>The transcription factor SOX9 regulates cartilage extracellular matrix gene expression and is essential for chondrocyte differentiation. We previously showed that activation of p38 MAPK by cycloheximide in human chondrocytes leads to stabilization of SOX9 mRNA (Tew SR and Hardingham TE. <I>J Biol Chem</I> 281: 39471&ndash;39479, 2006). In this study we investigated whether regulation of p38 MAPK caused by changes in osmotic pressure could control SOX9 mRNA levels expression by a similar mechanism. Primary human articular chondrocytes isolated from osteoarthritic cartilage at <I>passage 2</I>-<I>4</I> showed significantly raised SOX9 mRNA levels when exposed to hyperosmotic conditions for 5 h. The effect was strongest and most reproducible when actin stress fibers were disrupted by the Rho effector kinase inhibitor Y27632, or by culturing the cells within alginate beads. Freshly isolated chondrocytes, used within 24&ndash;48 h of isolation, did not contain actin stress fibers and upregulated SOX9 mRNA in response to hyperosmolarity in the presence and absence of Y27632. In these freshly isolated chondrocytes, hyperosmolarity led to an increase in the half-life of SOX9 mRNA, which was sensitive to the p38 MAPK inhibitor SB202190. SOX9 protein levels were increased by hyperosmotic culture over 24 h, and, in passaged chondrocytes, the activity of a COL2A1 enhancer driven luciferase assay was upregulated. However, in freshly isolated chondrocytes, COL2A1 mRNA levels were reduced by hyperosmotic conditions and the half-life was decreased. The results showed that the osmotic environment regulated both SOX9 and COL2A1 mRNA posttranscriptionally, but in fresh cells resulted in increased SOX9, but decreased COL2A1.</p>
]]></description>
<dc:creator><![CDATA[Tew, S. R., Peffers, M. J., McKay, T. R., Lowe, E. T., Khan, W. S., Hardingham, T. E., Clegg, P. D.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00571.2008</dc:identifier>
<dc:title><![CDATA[Hyperosmolarity regulates SOX9 mRNA posttranscriptionally in human articular chondrocytes]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C906</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C898</prism:startingPage>
<prism:section>RECEPTORS AND SIGNAL TRANSDUCTION</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C907?rss=1">
<title><![CDATA[Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C907?rss=1</link>
<description><![CDATA[
<p>Hypochlorous acid (HOCl) is a unique oxidant generated by the enzyme myeloperoxidase that contributes to endothelial cell dysfunction and death in atherosclerosis. Since myeloperoxidase localizes with heme oxygenase-1 (HO-1) in and around endothelial cells of atherosclerotic lesions, the present study investigated whether there was an interaction between these two enzymes in vascular endothelium. Treatment of human endothelial cells with the myeloperoxidase product HOCl stimulated a concentration- and time-dependent increase in HO-1 protein that resulted in a significant rise in carbon monoxide (CO) production. The induction of HO-1 protein was preceded by a prominent increase in HO-1 mRNA and total and nuclear factor-erythroid 2-related factor 2 (Nrf2). In addition, HOCl induced a significant rise in HO-1 promoter activity that was blocked by mutating the antioxidant response element (ARE) in the promoter or by overexpressing a dominant-negative mutant of Nrf2. The HOCl-mediated induction of Nrf2 or HO-1 was blocked by the glutathione donor <I>N</I>-acetyl-<scp>l</scp>-cysteine but was unaffected by ascorbic or uric acid. Finally, treatment of endothelial cells with HOCl stimulated mitochondrial dysfunction, caspase-3 activation, and cell death that was potentiated by the HO inhibitor, tin protoporphyrin-IX, or by the knockdown of HO-1, and reversed by the exogenous administration of biliverdin, bilirubin, or CO. These results demonstrate that HOCl induces HO-1 gene transcription via the activation of the Nrf2/ARE pathway to counteract HOCl-mediated mitochondrial dysfunction and cell death. The ability of HOCl to activate HO-1 gene expression may represent a critical adaptive response to maintain endothelial cell viability at sites of vascular inflammation and atherosclerosis.</p>
]]></description>
<dc:creator><![CDATA[Wei, Y., Liu, X.-m., Peyton, K. J., Wang, H., Johnson, F. K., Johnson, R. A., Durante, W.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00536.2008</dc:identifier>
<dc:title><![CDATA[Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C915</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C907</prism:startingPage>
<prism:section>VASCULAR BIOLOGY</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C916?rss=1">
<title><![CDATA[The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathway]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C916?rss=1</link>
<description><![CDATA[
<p>Intracorporal injection of plasmids encoding opiorphins into retired breeder rats can result in animals developing a priapic-like condition. Microarray analysis demonstrated that following intracorporal gene transfer of plasmids expressing opiorphins the most significantly upregulated gene in corporal tissue was the ornithine decarboxylase gene (ODC). Quantitative RT-PCR confirmed the upregulation of ODC, as well as other genes involved in polyamine synthesis, such as arginase-I and -II, polyamine oxidase, spermidine synthase, spermidine acetyltransferase (SAT), and <I>S</I>-adenosylmethionine decarboxylase. Western blot analysis demonstrated upregulation of arginase-I and -II, ODC, and SAT at the protein level. Levels of the polyamine putrescine were upregulated in animals treated with opiorphin-expressing plasmids compared with controls. A direct role for the upregulation of polyamine synthesis in the development of the priapic-like condition was supported by the observation that the ODC inhibitor 1,3-diaminopropane, when added to the drinking water of animals treated with plasmids expressing opiorphins, prevented experimental priapism. We also demonstrate that in sickle cell mice, another model of priapism, there is increased expression of the mouse opiorphin homologue in corporal tissue compared with the background strain at a life stage prior to evidence of priapism. At a life stage when there is onset of priapism, there is increased expression of the enzymes involved in polyamine synthesis (ODC and arginase-I and -II). Our results suggest that the upregulation of enzymes involved in the polyamine synthetic pathway may play a role in the development of experimental priapism and represent a target for the prevention of priapism.</p>
]]></description>
<dc:creator><![CDATA[Kanika, N. D., Tar, M., Tong, Y., Kuppam, D. S. R., Melman, A., Davies, K. P.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00656.2008</dc:identifier>
<dc:title><![CDATA[The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathway]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C927</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C916</prism:startingPage>
<prism:section>VASCULAR BIOLOGY</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C928?rss=1">
<title><![CDATA[Cytochrome c oxidase III as a mechanism for apoptosis in heart failure following myocardial infarction]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C928?rss=1</link>
<description><![CDATA[
<p>Cytochrome <I>c</I> oxidase (COX) is composed of 13 subunits, of which COX I, II, and III are encoded by a mitochondrial gene. COX I and II function as the main catalytic components, but the function of COX III is unclear. Because myocardial ischemia affects mitochondrial oxidative metabolism, we hypothesized that COX activity and expression would be affected during postischemic cardiomyopathy. This hypothesis was tested in a monkey model following myocardial infarction (MI) and subsequent pacing-induced heart failure (HF). In this model, COX I protein expression was decreased threefold after MI and fourfold after HF (<I>P</I> &lt; 0.05 vs. sham), whereas COX II expression remained unchanged. COX III protein expression increased 5-fold after MI and further increased 10-fold after HF compared with sham (<I>P</I> &lt; 0.05 vs. sham). The physiological impact of COX III regulation was examined in vitro. Overexpression of COX III in mitochondria of HL-1 cells resulted in an 80% decrease in COX I, 60% decrease in global COX activity, 60% decrease in cell viability, and threefold increase in apoptosis (<I>P</I> &lt; 0.05). Oxidative stress induced by H<SUB>2</SUB>O<SUB>2</SUB> significantly (<I>P</I> &lt; 0.05) increased COX III expression. H<SUB>2</SUB>O<SUB>2</SUB> decreased cell viability by 47 &plusmn; 3% upon overexpression of COX III, but only by 12 &plusmn; 5% in control conditions (<I>P</I> &lt; 0.05). We conclude that ischemic stress in vivo and oxidative stress in vitro lead to upregulation of COX III, followed by downregulation of COX I expression, impaired COX oxidative activity, and increased apoptosis. Therefore, upregulation of COX III may contribute to the increased susceptibility to apoptosis following MI and subsequent HF.</p>
]]></description>
<dc:creator><![CDATA[Wu, C., Yan, L., Depre, C., Dhar, S. K., Shen, Y.-T., Sadoshima, J., Vatner, S. F., Vatner, D. E.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00045.2009</dc:identifier>
<dc:title><![CDATA[Cytochrome c oxidase III as a mechanism for apoptosis in heart failure following myocardial infarction]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C934</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C928</prism:startingPage>
<prism:section>GROWTH, DIFFERENTIATION, AND APOPTOSIS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C935?rss=1">
<title><![CDATA[Caveolin-1 plays important role in EGF-induced migration and proliferation of mouse embryonic stem cells: involvement of PI3K/Akt and ERK]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C935?rss=1</link>
<description><![CDATA[
<p>The involvement of caveolin-1 in the regulation of embryonic stem (ES) cell growth by epidermal growth factor (EGF) is by no means clear cut. Thus we examined the relationship between EGF and caveolin-1 in mouse ES cell migration and proliferation. The results revealed that EGF increased Src, caveolin-1, focal adhesion kinase (FAK), Akt, and extracellular signal-regulated kinase-1/2 (ERK) phosphorylation levels. Especially, phosphorylation of caveolin-1 is attenuated by AG1478, herbimycin A (tyrosine kinase inhibitors), and pyrazolopyrimidine 2 (PP2, Src inhibitor) and EGF-induced ERK activation was blocked by PP2, methyl-&beta;-cyclodextrin (M&beta;CD), caveolin-1 small interfering RNA (siRNA), LY-294002 [phosphoinositol-3 kinase inhibitor (PI3K)], and Akt inhibitor. In addition, EGF promoted the cell migration, which was attenuated by PP2, caveolin-1 siRNA, FAK siRNA, LY-294002, Akt inhibitor, and PD-98059. EGF also increased matrix metalloproteinase (MMP-2) expression levels and EGF-induced MMP2 expression was inhibited by caveolin-1 siRNA, FAK siRNA, LY-294002, Akt inhibitor, and PD-98059. Furthermore, EGF-induced increase of cell cycle proteins expression level and [<sup>3</sup>H]thymidine incorporation was blocked by MMP inhibitor. EGF also significantly increases [<sup>3</sup>H]thymidine incorporation and cell number, which were significantly blocked by AG 1478, PP2, M&beta;CD, caveolin-1 siRNA, FAK siRNA, LY-294002, and PD-98059 (ERK inhibitor). EGF-induced increase of protooncogenes (c-<I>fo</I>s, c-<I>myc</I>, and c-<I>Jun</I>) and cell cycle regulatory proteins (cyclin D1, CDK4, cyclin E, and CDK2) expression levels were also attenuated by caveolin-1 siRNA and FAK siRNA. In conclusion, these results demonstrated that EGF-induced DNA synthesis and cell migration are mediated by caveolin-1, which is activated by Src, FAK, PI3K/Akt, ERK, and MMP-2 signals in mouse ES cells.</p>
]]></description>
<dc:creator><![CDATA[Park, J. H., Han, H. J.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00121.2009</dc:identifier>
<dc:title><![CDATA[Caveolin-1 plays important role in EGF-induced migration and proliferation of mouse embryonic stem cells: involvement of PI3K/Akt and ERK]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C944</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C935</prism:startingPage>
<prism:section>GROWTH, DIFFERENTIATION, AND APOPTOSIS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C945?rss=1">
<title><![CDATA[Endothelial barrier protection by FTY720 under hyperglycemic condition: involvement of focal adhesion kinase, small GTPases, and adherens junction proteins]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C945?rss=1</link>
<description><![CDATA[
<p>Recently, sphingosine 1-phosphate (S1P) has been highlighted as an endothelial barrier-stabilizing mediator. FTY720 is a S1P analog originally developed as a novel immunosuppressant. The phosphorylated form of FTY720 binds to S1P receptors to exert S1P-like biological effects, suggesting endothelial barrier promotion by FTY720. To elucidate whether FTY720 induces signaling events related to endothelial barrier enhancement under hyperglycemic conditions, human microvascular endothelial cells (HMVECs) preincubated with hyperglycemic (30 mM) medium were treated with 100 nM FTY720 for 3 h. Immunofluorescent microscopy and coprecipitation study revealed FTY720-induced focal adhesion kinase (FAK)-associated adherens junction (AJ) assembly at cell-cell contacts coincident with formation of a prominent cortical actin ring. FTY720 also induced transmonolayer electrical resistance (TER) augmentation in HMVEC monolayers in both normoglycemic and hyperglycemic conditions, implying endothelial barrier enhancement. Similar to S1P, site-specific FAK tyrosine phosphorylation analysis revealed FTY720-induced FAK [Y<sup>576</sup>] phosphorylation without phosphorylation of FAK [Y<sup>397</sup>/Y<sup>925</sup>]. Furthermore, FTY720 conditioned the phosphorylation profile of FAK [Y<sup>397</sup>/Y<sup>576</sup>/Y<sup>925</sup>] in hyperglycemic medium to the same pattern observed in normoglycemic medium. FTY720 challenge resulted in small GTPase Rac activation under hyperglycemic conditions, whereas increased Rho activity in hyperglycemic medium was restored to the basal level. Rac protein depletion by small interfering RNA (siRNA) technique completely abolished FTY720-induced FAK [Y<sup>576</sup>] phosphorylation. These findings strongly suggest the barrier protective effect of FTY720 on HMVEC monolayers in hyperglycemic medium via S1P signaling, further implying the possibility of FTY720 as a therapeutic agent of diabetic vascular disorder.</p>
]]></description>
<dc:creator><![CDATA[Sarai, K., Shikata, K., Shikata, Y., Omori, K., Watanabe, N., Sasaki, M., Nishishita, S., Wada, J., Goda, N., Kataoka, N., Makino, H.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00606.2008</dc:identifier>
<dc:title><![CDATA[Endothelial barrier protection by FTY720 under hyperglycemic condition: involvement of focal adhesion kinase, small GTPases, and adherens junction proteins]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C954</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C945</prism:startingPage>
<prism:section>EXTRACELLULAR MATRIX, CELL INTERACTIONS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C955?rss=1">
<title><![CDATA[Augmentation of Cav1 channel current and action potential duration after uptake of S100A1 in sympathetic ganglion neurons]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C955?rss=1</link>
<description><![CDATA[
<p>S100A1, a 21-kDa dimeric Ca<sup>2+</sup>-binding protein of the EF-hand type, is expressed in cardiomyocytes and is an important regulator of heart function. During ischemia, cardiomyocytes secrete S100A1 to the extracellular space. Although the effects of extracellular S100A1 have been documented in cardiomyocytes, it is unclear whether S100A1 exerts modulatory effects on other tissues in proximity with cardiac cells. Therefore, we sought to investigate the effects of exogenous S100A1 on Ca<sup>2+</sup> signals and electrical properties of superior cervical ganglion (SCG) neurons. Immunostaining and Western blot assays indicated no endogenous S100A1 in SCG neurons. Cultured SCG neurons took up S100A1 when it was present in the extracellular medium. Inside the cell exogenous S100A1 localized in a punctate pattern throughout the cytoplasm but was excluded from the nuclei. S100A1 partially colocalized with markers for both receptor- and non-receptor-mediated endocytosis, indicating that in SCG neurons multiple endocytotic pathways are involved in S100A1 internalization. In compartmentalized SCG cultures, axonal projections were capable of uptake and transport of S100A1 toward the neuronal somas. Exogenous S100A1 applied either extra- or intracellularly enhanced Ca<SUB>v</SUB>1 channel currents in a PKA-dependent manner, prolonged action potentials, and amplified action potential-induced Ca<sup>2+</sup> transients. NMR chemical shift perturbation of Ca<sup>2+</sup>-S100A1 in the presence of a peptide from the regulatory subunit of PKA verifies that S100A1 directly interacts with PKA, and that this interaction likely occurs in the hydrophobic binding pocket of Ca<sup>2+</sup>-S100A1. Our results suggest the hypothesis that in sympathetic neurons exogenous S100A1 may lead to an increase of sympathetic output.</p>
]]></description>
<dc:creator><![CDATA[Hernandez-Ochoa, E. O., Prosser, B. L., Wright, N. T., Contreras, M., Weber, D. J., Schneider, M. F.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00140.2009</dc:identifier>
<dc:title><![CDATA[Augmentation of Cav1 channel current and action potential duration after uptake of S100A1 in sympathetic ganglion neurons]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C970</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C955</prism:startingPage>
<prism:section>NERVOUS SYSTEM CELL BIOLOGY</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C971?rss=1">
<title><![CDATA[Caffeine inhibits nonselective cationic currents in interstitial cells of Cajal from the murine jejunum]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C971?rss=1</link>
<description><![CDATA[
<p>Interstitial cells of Cajal (ICC) discharge unitary potentials in gastrointestinal muscles that constitute the basis for pacemaker activity. Caffeine has been used to block unitary potentials, but the ionic conductance responsible for unitary potentials is controversial. We investigated currents in cultured ICC from murine jejunum that may underlie unitary potentials and studied the effects of caffeine. Networks of ICC generated slow wave events under current clamp, and these events were blocked by caffeine in a concentration-dependent manner. Single ICC generated spontaneous transient inward currents (STICs) under voltage clamp at &ndash;60 mV and noisy voltage fluctuations in current clamp. STICs were unaffected when the equilibrium potential for Cl<sup>&ndash;</sup> (<I>E</I><SUB>Cl</SUB>) was set to &ndash;60 mV (excluding Cl<sup>&ndash;</sup> currents) and reversed at 0 mV, demonstrating that a nonselective cationic conductance, and not a Cl<sup>&ndash;</sup> conductance, is responsible for STICs in ICC. Caffeine inhibited STICs in a concentration-dependent manner. Reduced intracellular Ca<sup>2+</sup> and calmidazolium (CMZ; 1 &micro;M) activated persistent inward, nonselective cation currents in ICC. Currents activated by CMZ and by dialysis of cells with 10 mM BAPTA were also inhibited by caffeine. Excised inside-out patches contained channels that exhibited spontaneous openings, and resulting currents reversed at 0 mV. Channel openings were increased by reducing Ca<sup>2+</sup> concentration from 10<sup>&ndash;6</sup> M to 10<sup>&ndash;8</sup> M. CMZ (1 &micro;M) also increased openings of nonselective cation channels. Spontaneous currents and channels activated by CMZ were inhibited by caffeine (5 mM). The findings demonstrate that the Ca<sup>2+</sup>-inhibited nonselective cation channels that generate STICs in ICC are blocked directly by caffeine. STICs are responsible for unitary potentials in intact muscles, and the block of these events by caffeine is consistent with the idea that a nonselective cation conductance underlies unitary potentials in ICC.</p>
]]></description>
<dc:creator><![CDATA[Jin, N. G., Koh, S. D., Sanders, K. M.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00155.2009</dc:identifier>
<dc:title><![CDATA[Caffeine inhibits nonselective cationic currents in interstitial cells of Cajal from the murine jejunum]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C978</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C971</prism:startingPage>
<prism:section>MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C979?rss=1">
<title><![CDATA[Secretory state regulates Zn2+ transport in gastric parietal cell of the rabbit]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C979?rss=1</link>
<description><![CDATA[
<p>Secretory compartments of neurons, endocrine cells, and exocrine glands are acidic and contain high levels of labile Zn<sup>2+</sup>. Previously, we reported evidence that acidity is regulated, in part, by the content of Zn<sup>2+</sup> in the secretory [i.e., tubulovesicle (TV)] compartment of the acid-secreting gastric parietal cell. Here we report studies focusing on the mechanisms of Zn<sup>2+</sup> transport by the TV compartment in the mammalian (rabbit) gastric parietal cell. Uptake of Zn<sup>2+</sup> by isolated TV structures was monitored with a novel application of the fluorescent Zn<sup>2+</sup> reporter <I>N</I>-(6-methoxy-8-quinolyl)-<I>para</I>-toluenesulfonamide (TSQ). Uptake was suppressed by removal of external ATP or blockade of H<sup>+</sup>-K<sup>+</sup>-ATPase that mediates luminal acid secretion. Uptake was diminished with dissipation of the proton gradient across the TV membrane, suggesting Zn<sup>2+</sup>/H<sup>+</sup> antiport as the connection between Zn<sup>2+</sup> uptake and acidity in the TV lumen. In isolated gastric glands loaded with the reporter fluozin-3, inhibition of H<sup>+</sup>-K<sup>+</sup>-ATPase arrested the flow of Zn<sup>2+</sup> from the cytoplasm to the TV compartment and secretory stimulation with forskolin enhanced vectorial movement of cytoplasmic Zn<sup>2+</sup> into the tubulovesicle/lumen (TV/L) compartment. Our findings suggest that Zn<sup>2+</sup> accumulation in the TV/L compartment is physiologically coupled to secretion of acid. These findings offer novel insight into mechanisms regulating Zn<sup>2+</sup> homeostasis in the gastric parietal cell and potentially other cells in which acidic subcellular compartments serve signature functional roles.</p>
]]></description>
<dc:creator><![CDATA[Naik, H. B., Beshire, M., Walsh, B. M., Liu, J., Soybel, D. I.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00577.2008</dc:identifier>
<dc:title><![CDATA[Secretory state regulates Zn2+ transport in gastric parietal cell of the rabbit]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C989</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C979</prism:startingPage>
<prism:section>MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C990?rss=1">
<title><![CDATA[Activation of maxi-anion channel by protein tyrosine dephosphorylation]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C990?rss=1</link>
<description><![CDATA[
<p>The maxi-anion channel with a large single-channel conductance of &gt;300 pS, and unknown molecular identity, is functionally expressed in a large variety of cell types. The channel is activated by a number of experimental maneuvers such as exposing cells to hypotonic or ischemic stress. The most effective and consistent method of activating it is patch membrane excision. However, the activation mechanism of the maxi-anion channel remains poorly understood at present. In the present study, involvement of phosphorylation/dephosphorylation in excision-induced activation was examined. In mouse mammary fibroblastic C127 cells, activity of the channel was suppressed by intracellular application of Mg-ATP, but not Mg-5'-adenylylimidodiphosphate (AMP-PNP), in a concentration-dependent manner. When a cocktail of broad-spectrum tyrosine phosphatase inhibitors was applied, channel activation was completely abolished, whereas inhibitors of serine/threonine protein phosphatases had no effect. On the other hand, protein tyrosine kinase inhibitors brought the channel out of an inactivated state. In mouse adult skin fibroblasts (MAFs) in primary culture, similar maxi-anion channels were found to be activated on membrane excision, in a manner sensitive to tyrosine phosphatase inhibitors. In MAFs isolated from animals deficient in receptor protein tyrosine phosphatase (RPTP), activation of the maxi-anion channel was significantly slower and less prominent compared with that observed in wild-type MAFs; however, channel activation was restored by transfection of the RPTP gene. Thus it is concluded that activation of the maxi-anion channel involves protein dephosphorylation mediated by protein tyrosine phosphatases that include RPTP in mouse fibroblasts, but not in C127 cells.</p>
]]></description>
<dc:creator><![CDATA[Toychiev, A. H., Sabirov, R. Z., Takahashi, N., Ando-Akatsuka, Y., Liu, H., Shintani, T., Noda, M., Okada, Y.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:08 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00131.2009</dc:identifier>
<dc:title><![CDATA[Activation of maxi-anion channel by protein tyrosine dephosphorylation]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1000</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C990</prism:startingPage>
<prism:section>MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C1001?rss=1">
<title><![CDATA[Regulation of Kir channels in bovine retinal pigment epithelial cells by phosphatidylinositol 4,5-bisphosphate]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C1001?rss=1</link>
<description><![CDATA[
<p>The inwardly rectifying K<sup>+</sup> (Kir) current in mammalian retinal pigment epithelial (RPE) cells, which is largely mediated by Kir7.1 channels, is stable in cells dialyzed with MgATP but runs down when intracellular ATP is depleted. A potential mechanism for this rundown is a decrease in phosphatidylinositol 4,5-bisphosphate (PIP<SUB>2</SUB>) regeneration by ATP-dependent lipid kinases. Here, we used the whole cell voltage-clamp technique to investigate the membrane PIP<SUB>2</SUB> dependence of Kir channels in isolated bovine RPE cells. When RPE cells were dialyzed with ATP-free solution containing PIP<SUB>2</SUB> (25&ndash;50 &micro;M), rundown persisted but was markedly reduced. Removal of Mg<sup>2+</sup> from the pipette solution also slowed rundown, indicating that elevated intracellular Mg<sup>2+</sup> concentration contributes to rundown. Cell dialysis with the PIP<SUB>2</SUB> scavenger neomycin in MgATP solution diminished Kir current in a voltage-dependent manner, suggesting that it acted at least in part by blocking the Kir channel. Kir current in MgATP-loaded cells was partially inhibited by bath application of quercetin (100 &micro;M), phenylarsine oxide (100 &micro;M), or wortmannin (50 &micro;M), inhibitors of phosphatidylinositol (PI) kinases, and was completely inhibited by cell dialysis with 2 mM adenosine, a PI4 kinase inhibitor. Both LY-294002 (100 &micro;M), an inhibitor of PI3 kinases, and its inactive analog LY-303511 (100 &micro;M) rapidly and reversibly inhibited Kir current, suggesting that these compounds act as direct channel blockers. We conclude that the activity of Kir channels in the RPE is critically dependent on the regeneration of membrane PIP<SUB>2</SUB> by PI4 kinases and that this may explain the dependence of these channels on hydrolyzable ATP.</p>
]]></description>
<dc:creator><![CDATA[Pattnaik, B. R., Hughes, B. A.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:09 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00250.2009</dc:identifier>
<dc:title><![CDATA[Regulation of Kir channels in bovine retinal pigment epithelial cells by phosphatidylinositol 4,5-bisphosphate]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1011</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C1001</prism:startingPage>
<prism:section>MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C1012?rss=1">
<title><![CDATA[Different roles of H-ras for regulation of myosin heavy chain promoters in satellite cell-derived muscle cell culture during proliferation and differentiation]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C1012?rss=1</link>
<description><![CDATA[
<p>The effect of constitutively activated proto-oncogene H-ras (H-rasQ61L) on the regulation of myosin heavy chain (MHC) promoter activities was investigated in rabbit satellite cell-derived muscle cell culture during the proliferation stage and early and later stages of differentiation, respectively. During proliferation, overexpression of H-rasQ61L did not affect basal level of activity of the slow MHCI/&beta; or the fast MHCIId/x promoter luciferase reporter gene construct in transient transfection assays. By contrast, H-rasQ61L affected both MHC promoter activities during differentiation, and this effect changes from inactivation after 2 days to activation after 4 days of differentiation. The activating effect of H-rasQ61L on both MHC promoters after 4 days of differentiation was significantly reduced by LY-294002, a specific inhibitor of the phosphoinositol-3-kinase (PI3K), a downstream target of Ras. Furthermore, the protein kinase Akt (protein kinase B), a downstream target of PI3k, was activated 4 days after initiation of differentiation in myotubes overexpressing H-rasQ61L. By contrast, inhibition of another Ras downstream pathway, mitogen-activated protein kinase kinase 1/2-extracellular signal-regulated protein kinase 1/2 (MKK1/2-ERK1/2-MAPK), increased activities of both MHC promoters, indicating a suppressive role of this pathway. Moreover, the Ras-PI3K-Akt signaling pathway is involved in the activation of MHCI/&beta; and IId/x promoters in a later stage of differentiation of muscle cells, presumably by a known inhibiting effect of activated Akt on the MKK1/2-ERK1/2-MAPK pathway. The experiments demonstrate that during differentiation of muscle cells activated H-ras is an important regulator of MHC isoform promoter function with opposite effects during early and later stages.</p>
]]></description>
<dc:creator><![CDATA[Scholz, M. E., Meissner, J. D., Scheibe, R. J., Umeda, P. K., Chang, K.-C., Gros, G., Kubis, H.-P.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:09 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00567.2008</dc:identifier>
<dc:title><![CDATA[Different roles of H-ras for regulation of myosin heavy chain promoters in satellite cell-derived muscle cell culture during proliferation and differentiation]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1018</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C1012</prism:startingPage>
<prism:section>MUSCLE CELL BIOLOGY AND CELL MOTILITY</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C1019?rss=1">
<title><![CDATA[IGF-I activates the mouse type IIb myosin heavy chain gene]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C1019?rss=1</link>
<description><![CDATA[
<p>IGF-I increases skeletal muscle mass, but whether IGF-I increases type IIb myosin heavy chain (MyHC) transcriptional activity is not known. C<SUB>2</SUB>C<SUB>12</SUB> myotubes were cultured with or without IGF-I to determine whether IGF-I increases type IIb MyHC promoter activity, and if so, what region of the promoter might IGF-I signaling regulate. At differentiation <I>days 3</I> and <I>4</I>, IGF-I increased type IIb MyHC mRNA and mouse 3.0-kb type IIb MyHC promoter activity. Deletion construct studies identified a potential IGF-I-responsive region between 1.25 and 1.2 kb of the type IIb MyHC promoter, which contained an exact 6-bp T-cell factor/lymphoid enhancer factor (Tcf/Lef) binding site at position &ndash;1206 to &ndash;1201. Site-specific mutation of the putative Tcf/Lef binding site reduced IGF-I-induced 1.3-kb type IIb MyHC promoter activity. To identify potential IGF-I signaling molecules, the phosphatidylinositol 3-kinase (PI3K) inhibitors wortmannin and LY-294002 were both found to markedly attenuate IGF-I activation of the 1.3-kb type IIb MyHC promoter. Downstream signaling of IGF-I can phosphorylate and inactivate GSK-3&beta;, thereby enhancing &beta;-catenin protein. The GSK-3&beta; inhibitor, LiCl, dramatically enhanced IGF-I induction of the 1.3-kb type IIb MyHC promoter, and constitutively active GSK-3&beta; attenuated IGF-I-induced 1.3-kb type IIb MyHC promoter activity. Finally, IGF-I increased nuclear &beta;-catenin protein, and small interfering RNA knockdown of &beta;-catenin attenuated IGF-I-induced 1.3-kb type IIb MyHC promoter activity and type IIb MyHC mRNA. In summary, IGF-I stimulation of C<SUB>2</SUB>C<SUB>12</SUB> myotubes increases mouse type IIb MyHC promoter activity, likely through signaling of PI3K, GSK-3&beta;, &beta;-catenin, and a Tcf/Lef binding site at &ndash;1,206 to &ndash;1,201 bp in the promoter.</p>
]]></description>
<dc:creator><![CDATA[Shanely, R. A., Zwetsloot, K. A., Childs, T. E., Lees, S. J., Tsika, R. W., Booth, F. W.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:09 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00169.2009</dc:identifier>
<dc:title><![CDATA[IGF-I activates the mouse type IIb myosin heavy chain gene]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1027</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C1019</prism:startingPage>
<prism:section>MUSCLE CELL BIOLOGY AND CELL MOTILITY</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C1028?rss=1">
<title><![CDATA[Functional characterization of two isoforms of the P2Y-like receptor GPR17: [35S]GTP{gamma}S binding and electrophysiological studies in 1321N1 cells]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C1028?rss=1</link>
<description><![CDATA[
<p>The previously "orphan" G protein-coupled receptor GPR17 is structurally related to both P2Y nucleotide receptors and to receptors for cysteinyl leukotrienes. Genomic analysis revealed two putative open reading frames encoding for a "short" and a "long" receptor isoform of 339- and 367-amino acids, respectively, with the latter displaying a 28-amino acid longer NH<SUB>2</SUB> terminus. The short isoform has been recently "deorphanized," revealing dual responses to uracil nucleotides and cysteinyl leukotrienes. No information regarding the ligand specificity, tissue distribution, or pathophysiological roles of the long receptor isoform is available. In the present study, we cloned human long-GPR17, determined its tissue distribution, and characterized its pharmacological specificity in 1321N1 cells by [<sup>35</sup>S]GTPS binding (which measures the ability of G protein-coupled receptor agonists to increase GTP binding to G proteins) and whole cell patch-clamp recording measuring receptor coupling to K<sup>+</sup> channels. [<sup>35</sup>S]GTPS binding in long-GPR17-expressing 1321N1 cells revealed concentration-dependent responses to uracil nucleotides (UDP-galactose = UDP &gt; UDP-glucose) and cysteinyl leukotrienes (LTC<SUB>4</SUB> &gt; LTD<SUB>4</SUB>), which were counteracted by a purinergic (cangrelor) and a cysteinyl leukotriene antagonist (montelukast), respectively. The nonhydrolyzable ATP analog ATPS also acted as an antagonist. GPR17 coupled to G<SUB>i</SUB> and, to a lesser extent, G<SUB>q</SUB> proteins. UDP-glucose and LTD<SUB>4</SUB> also induced increases in overall outward K<sup>+</sup> currents, which were antagonized by the purinergic antagonists MRS2179 and cangrelor and by montelukast. We conclude that the previously uncharacterized long-GPR17 isoform is a functional receptor that is stimulated by both uracil nucleotides and cysteinyl leukotrienes. We also show that the signaling pathway of GPR17 involves the generation of outward K<sup>+</sup> currents, an important protective mechanism that, in brain, is specifically aimed at reducing neuronal hyperexcitability and resultant neuronal injury.</p>
]]></description>
<dc:creator><![CDATA[Pugliese, A. M., Trincavelli, M. L., Lecca, D., Coppi, E., Fumagalli, M., Ferrario, S., Failli, P., Daniele, S., Martini, C., Pedata, F., Abbracchio, M. P.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:09 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00658.2008</dc:identifier>
<dc:title><![CDATA[Functional characterization of two isoforms of the P2Y-like receptor GPR17: [35S]GTP{gamma}S binding and electrophysiological studies in 1321N1 cells]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1040</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C1028</prism:startingPage>
<prism:section>RECEPTORS AND SIGNAL TRANSDUCTION</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C1041?rss=1">
<title><![CDATA[A-769662 activates AMPK {beta}1-containing complexes but induces glucose uptake through a PI3-kinase-dependent pathway in mouse skeletal muscle]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C1041?rss=1</link>
<description><![CDATA[
<p>5'-AMP-activated protein kinase (AMPK) regulates several aspects of metabolism. Recently, A-769662 was shown to activate AMPK in skeletal muscle. However, no biological effects of AMPK activation by A-769662 in this tissue have been reported. We hypothesized that A-769662 would increase glucose uptake in skeletal muscle. We studied incubated soleus and extensor digitorum longus (EDL) muscles from 129S6/sv and C57BL/6 mice. Glucose uptake increased only in soleus from 129S6/sv when concentrations of A-769662 were 500 &micro;M (~15%, <I>P</I> &lt; 0.05) and 1 mM (~60%, <I>P</I> &lt; 0.01). AMPK &beta;<SUB>1</SUB>- but not &beta;<SUB>2</SUB>-containing complexes were dose dependently activated by A-769662 in muscles from both genotypes (~100% at 200 &micro;M and 300&ndash;600% at 1 mM). The discrepancy between the A-769662-induced AMPK activation pattern and stimulation of glucose uptake suggested that these effects were unrelated. A-769662 increased phosphorylation of Akt in both muscles from both genotypes, with phosphorylation of T308 being significantly higher in soleus than in EDL in 129S6/sv mice (<I>P</I> &lt; 0.01). In soleus from 129S6/sv mice, insulin receptor substrate 1-associated phosphatidylinositol 3 (PI3)-kinase activity was markedly increased with A-769662, and Akt phosphorylation and glucose uptake were inhibited by wortmannin while phosphorylation of acetyl-CoA carboxylase (S227) was unaffected. Thus, A-769662 activates &beta;<SUB>1</SUB>-containing AMPK complexes in skeletal muscle but induces glucose uptake through a PI3-kinase-dependent pathway. Although development of A-769662 has constituted a step forward in the search for AMPK activators targeting specific AMPK trimers, our data suggest that in intact muscle, A-769662 has off-target effects. This may limit use of A-769662 to study the role of AMPK in skeletal muscle metabolism.</p>
]]></description>
<dc:creator><![CDATA[Treebak, J. T., Birk, J. B., Hansen, B. F., Olsen, G. S., Wojtaszewski, J. F. P.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:09 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00051.2009</dc:identifier>
<dc:title><![CDATA[A-769662 activates AMPK {beta}1-containing complexes but induces glucose uptake through a PI3-kinase-dependent pathway in mouse skeletal muscle]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1052</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C1041</prism:startingPage>
<prism:section>RECEPTORS AND SIGNAL TRANSDUCTION</prism:section>
</item>

<item rdf:about="http://ajpcell.physiology.org/cgi/content/abstract/297/4/C1053?rss=1">
<title><![CDATA[Rab34 and its effector munc13-2 constitute a new pathway modulating protein secretion in the cellular response to hyperglycemia]]></title>
<link>http://ajpcell.physiology.org/cgi/content/abstract/297/4/C1053?rss=1</link>
<description><![CDATA[
<p>Diabetic nephropathy (DN) is the leading cause of end-stage renal disease requiring dialysis in the Western world. Clinical studies reveal that stringent control of blood glucose levels reduces the risk of most diabetic complications, underscoring the importance of understanding the cellular response to hyperglycemia. Our work identifies a new pathway of potential significance in this response, linking hyperglycemia to the stimulation of constitutive protein secretion via a pathway involving munc13 and rab34. These two proteins have previously been shown to interact at the Golgi via the munc13 homology domain 2 (MHD2). In the present study, using cultured rat mesangial cells (RMC), we show that high glucose-induced upregulation of endogenous munc13-2 increases secretion of the model protein, vesicular stomatitis virus glycoprotein-green fluorescent protein (VSVG-GFP), while small interfering (si)RNA-mediated knockdown of either munc13-2 or rab34 abolishes this effect. Similarly, increased secretion of VSVG-GFP is observed following transfection of HeLa cells with wild-type munc13-2, but not when HeLa cells are transfected with a mutant protein in which the MHD2 domain is deleted. Finally, we show that high glucose-stimulated secretion of fibronectin in RMC is abolished by siRNA knockdown of munc13-2. Collectively, our results demonstrate that the mechanistic basis for our observed high glucose-induced protein secretion is through interaction of munc13 and rab34, indicating a potentially critical role for this newly described pathway in the pathogenesis of DN.</p>
]]></description>
<dc:creator><![CDATA[Goldenberg, N. M., Silverman, M.]]></dc:creator>
<dc:date>Thu, 01 Oct 2009 14:03:09 PDT</dc:date>
<dc:identifier>info:doi/10.1152/ajpcell.00286.2009</dc:identifier>
<dc:title><![CDATA[Rab34 and its effector munc13-2 constitute a new pathway modulating protein secretion in the cellular response to hyperglycemia]]></dc:title>
<dc:publisher>American Physiological Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>297</prism:volume>
<prism:endingPage>C1058</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>C1053</prism:startingPage>
<prism:section>PROTEIN AND VESICLE TRAFFICKING, CYTOSKELETON</prism:section>
</item>

</rdf:RDF>